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  Abstract 
  i 
Abstract 
The evolutionary conserved Notch signaling pathway mediates direct communication between 
adjacent cells and plays a pivotal role in somite formation and patterning during 
embryogenesis. The Notch ligands Dll1 and Dll3 are both essential for somitogenesis in 
mammals. However, despite their largely overlapping expression domains in the presomitic 
mesoderm of mouse embryos, Dll1 and Dll3 null mutant mice display strikingly different 
somite defects. Additionally, the DLL1 and DLL3 proteins differ with respect to various 
domains suggesting that both proteins are biochemically not equivalent and exert non-
redundant functions during somitogenesis. 
In this study, it was demonstrated that DLL3 does not induce Notch signaling in 
transactivation assays. Providing a ‘trivial’ explanation, the DLL3 protein does not localize to 
the cell surface but accumulates inside the cell. Subcellular localization studies in the 
presomitic mesoderm of mouse embryos revealed that endogenous DLL3 predominantly 
localizes to the Golgi apparatus whereas endogenous DLL1 is expressed at the cell 
membrane. In vitro analyses of cell surface presentation and subcellular localization of DLL1-
DLL3 chimeric ligands demonstrated that the transmembrane domain and juxtamembrane 
sequences of DLL3 harbor recognition sequences that are responsible for Golgi retention of 
the protein. Furthermore, the DSL domain of DLL1 appears to be necessary in order to direct 
cell surface presentation. In combination with EGF-like repeats 1 and 2 and the 
transmembrane and intracellular domain, the DSL domain of DLL1 seems sufficient to 
activate Notch signaling as determined by transactivation assays. In addition, two conserved 
amino acid motifs in the DSL domain of DLL1 that are not present in the divergent DSL 
domain of DLL3, were shown to be necessary for efficient cell surface presentation and for 
DLL1 function.  
The analysis of presomitic mesoderm of Dll3 mutant pudgy embryos showed that the loss of 
Dll3 has only a low impact on Notch activation suggesting that DLL3 does not exert 
antagonistic but rather modulatory influence on Notch signaling.  
As part of this study the Dll3 coding sequence was inserted into the Dll1 locus by targeted 
recombination, thus exchanging the endogenous expression of Dll1 for that of Dll3. This 
presented a pivotal prerequisite for the analysis of the functional non-equivalence of Dll1 and 
Dll3 in vivo. 
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Zusammenfassung 
Der konservierte Notch-Signalweg vermittelt die Kommunikation zwischen benachbarten 
Zellen und spielt eine Schlüsselrolle in der Somiten- und Musterbildung während der 
Embryonalentwicklung. Die Notch-Liganden Dll1 und Dll3 sind beide unentbehrlich für eine 
normale Somitenbildung in Säugetieren. Trotz der weitgehend überlappenden Expressions-
muster im präsomitischen Mesoderm von Mausembryonen, zeigen Mäuse mit Nullallelen von 
Dll1 und Dll3 unterschiedliche Somitendefekte. Zusätzlich legen Unterschiede in der Protein-
struktur von DLL1 und DLL3 die Vermutung nahe, dass beide Faktoren biochemisch nicht 
äquivalent sind und unterschiedliche Funktionen während der Somitenbildung übernehmen. 
In dieser Studie wurde gezeigt, dass DLL3 kein echter Notch-Ligand ist, da es keine Notch-
Aktivierung auslöst. Dies ist darauf zurückzuführen, dass DLL3 nicht auf der Zelloberfläche 
präsent ist, sondern intrazellulär akkumuliert. Die Analyse der subzellulären Lokalisierung 
von DLL3 im präsomitischen Mesoderm von Mausembryonen zeigte, dass endogenes DLL3 
im Gegensatz zu DLL1 überwiegend im Golgi-Netzwerk und nicht auf der Zelloberfläche 
lokalisiert ist. Die Untersuchung von Dll1-Dll3-chimären Liganden im Hinblick auf 
Zelloberflächenpräsentation und subzelluläre Lokalisierung der Proteine zeigte, dass die 
Transmembrandomäne von DLL3 zusammen mit benachbarten Regionen Signalsequenzen 
aufweist, die für das Zurückhalten des Proteins im Golgi-Apparat verantwortlich sind. Für 
eine effiziente Oberflächenlokalisierung der chimären Liganden war die DSL-Domäne von 
DLL1 zwingend erforderlich. Für das Transaktivierungspotential der chimären Liganden ist 
die Präsenz des N-Terminus einschließlich der DSL-Domäne und der ersten beiden EGF-
ähnlichen Domänen zusammen mit der Transmembran- und intrazellulären Domäne von 
DLL1 ausreichend. Weiterhin wurde gezeigt, dass zwei konservierte Aminosäuremotive in 
der DSL-Domäne von DLL1, die in der DSL-Domäne von DLL3 fehlen, unerlässlich für die 
korrekte Lokalisierung und Aktivatorfunktion von DLL1 sind. Die Analyse von präsomi-
tischem Mesoderm aus Dll3-mutanten Mausembryonen zeigte, dass der Verlust von DLL3 
kaum Auswirkung auf das Ausmaß der Notch-Aktivierung hat. Diese Beobachtung legt nahe, 
dass die Funktion von Dll3 einen eher modulatorischen als antagonistischen Einfluß auf die 
Notch-Aktivierung während der Somitogenese ausübt. Als weiterer Teil dieser Studie wurde 
die kodierende Sequenz von Dll3 in den Dll1 Locus der Maus eingebracht, um die endogene 
Expression von Dll1 durch Dll3 zu ersetzen und so die Voraussetzung für die Analyse einer 
möglichen funktionellen Redundanz von Dll1 und Dll3 in vivo zu schaffen. 
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1 Introduction 
A limited set of signaling pathways is active during embryogenesis and crucial for the 
development of the embryo into a healthy organism. The major signaling pathways acting 
during vertebrate development are the Wnt, JAK/STAT, Hedgehog, receptor tyrosine kinase 
(e.g. FGF signaling), TGF-β (e.g. BMP signaling) and the Notch signaling pathway. These 
pathways are interconnected and together control the gene regulatory program required for 
proper embryonic development by inhibitory and/or activating crosstalk (Axelrod et al., 1996; 
Shaye and Greenwald, 2002; Wahl et al., 2007; Yoo et al., 2004). 
1.1 Somitogenesis in mice 
The developing mouse embryo is a well established model to analyze the molecular genetics 
and function of signaling cascades involved in the regulation of growth and patterning. One 
example is the tightly regulated process of somite formation (somitogenesis) that is important 
for organizing the segmental pattern of the body during early embryonic development 
(Gossler and Tam, 2002).  
During gastrulation the unsegmented paraxial mesoderm emerges as a mesodermal 
subpopulation from the primitive streak and locates bilaterally to the midline of the embryo. 
In this so-called presomitic mesoderm (PSM) morphologically distinct spherical units of 
mesenchymal cells (somitomeres) become compacted, epithelialize and eventually bud off the 
rostral end of the paraxial mesoderm to form a somite (Fig. 1.1). Throughout somite 
formation continuous proliferation of a pool of progenitor cells in the primitive streak and 
later in the tail bud ensures the supply of cells in the presomitic mesoderm. 
Somites are transient metameric structures. Shortly after their formation the epithelial somites 
differentiate into sclerotome and dermomyotome by undergoing localized epithelial-
mesenchymal transition. Later the sclerotome gives rise to the vertebrae, the intervertebral 
discs and the ribs. The dermomyotome forms the dermis of the dorsal skin, the skeletal 
muscle of the back, the body wall and the limbs. 
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Fig. 1.1: Somitogenesis in the mouse embryo 
(Saga and Takeda, 2001). Epithelial somites 
bud off sequentially from the rostral end of the 
presomitic mesoderm (PSM), while more PSM 
cells are supplied from the paraxial mesoderm 
in the caudal region of the tailbud. Arrows 
show previously formed somite segment 
borders.  
The formation of somites occurs at regular intervals in a coordinated manner at both sides of 
the neural tube. The periodicity is mediated by a ‘segmentation clock’ that intrinsically 
oscillates within the PSM in a rostro-caudal fashion. Through cyclic gene expression in the 
posterior presomitic mesoderm the formation of somites is spatially and temporally controlled 
(Aulehla and Herrmann, 2004; Pourquie, 2003). The period of wavelike gene expression 
correlates with the creation of a somitic boundary within 120 min in mice. For instance, 
dynamic expression of Lunatic fringe (Lfng), a modulator of Notch signaling, and its confined 
localization to the presumptive somite border region mediates the formation of morphological 
boundaries (Aulehla and Johnson, 1999; Sato et al., 2002). Notch signaling plays an 
important role in the clock mechanism. However, somites still form when Notch signaling is 
impaired or abolished, suggesting that additional factors must be involved (Oka et al., 1995). 
The origin of the autonomous oscillation of gene expression is still a subject of controversial 
discussions and several models were proposed to explain the mechanisms underlying 
somitogenesis (Baker et al., 2006). The number of somites and the cycling period of somite 
formation are specific for each organism, and have been extensively studied in zebrafish, 
mouse and chicken embryos (Rida et al., 2004; Tam, 1981). 
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The presomitic mesoderm gains positional identity along the anterior-posterior (AP) body 
axis specified by the expression of particular Hox genes (Cordes et al., 2004; Kessel and 
Gruss, 1991; Krumlauf, 1994; Nowicki and Burke, 2000). This positional specification of 
future mesoderm derivatives is coupled to Notch signaling and the segmentation clock 
(Cordes et al., 2004). Similarly, the somitomeres themselves establish an antero-posterior 
(AP) polarity leading to a subdivision into an anterior and a posterior compartment of the 
somite that show differential cell properties and expression of marker genes (Fig. 1.2; Keynes 
and Stern, 1984; Keynes and Stern, 1988). Compartmentalization of the somites was 
demonstrated by rotating newly formed somites along their AP axis in transplantation 
experiments which results in the development of vertebrae with the corresponding inverse 
polarity (Aoyama and Asamoto, 1988). The antero-posterior pre-patterning originates on the 
basis of a molecular patterning in the anterior end of the unsegmented PSM. Several factors 
intrinsic to the somitic mesoderm of the vertebrate embryo are known to control AP polarity 
within somites prior to formation of epithelial somites. By interaction of the Notch signaling 
pathway with the basic helix–loop–helix transcription factor Mesp2 (mesoderm posterior 2), 
somite compartmentalization is established (Saga et al., 1997). Complex feedback loops of 
Mesp2 function eventually lead to differential expression of the Notch ligand Dll1 in the 
somite compartments and to polarized expression of the transcription factors Tbx18 (anterior) 
rostral
presomitic
mesoderm
caudal
somite
formation
definition of prospective
antero-posterior somitic
compartments
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specification
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Fig. 1.2: Major events taking place 
in presomitic mesoderm (Pourquie 
and Kusumi, 2001). Proliferation of 
stem cells in the tail bud provides the 
supply of mesodermal cells in the 
presomitic mesoderm (PSM). Oscilla-
tions of the ‘segmentation clock’ lead 
to segment specification. In the 
anterior (rostral) PSM prospective 
antero-posterior somite polarity is 
defined prior to somite formation. SI 
and SII indicate already formed 
somites.  
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and Uncx4.1 (posterior) (Haenig and Kispert, 2004; Mansouri et al., 1997; Takahashi et al., 
2000; Takahashi et al., 2003). Concerted action of Tbx18 and Uncx4.1 is required to maintain 
the separation of anterior and posterior somite compartments presumably by preventing 
migration of anterior or posterior cells into the neighboring compartment (Bussen et al., 
2004). A link between segment polarity and somite morphogenesis is provided by expression 
of Eph/ephrin signaling components in polarized stripes in the PSM mediating cell contact 
repulsion and differential permissiveness of the somite compartments to migrating neural 
crest cell, motor neurons and intersegmental blood vessels (Adams et al., 1999; Krull, 2001). 
While somitogenesis itself proceeds without the requirement for continuous interactions with 
surrounding tissues, the further differentiation of the somites relies on inductive or inhibitory 
paracrine signals from proximal tissues such as the surface ectoderm, the neural tube and the 
notochord (Kieny et al., 1972). The dorsal part of the somite retains its epithelial organization 
and becomes precursor tissue of the dermis and the myotome (Ikeya and Takada, 1998; 
Marcelle et al., 1997; Pourquie et al., 1996). The ventro-medial part of the somite 
differentiates into sclerotome which is subdivided into a cranial (anterior) and a caudal 
(posterior) half (Ebner, 1888; Fan and Tessier-Lavigne, 1994; Johnson et al., 1994). In a 
resegmentation process, the caudal sclerotome of one somite fuses with cells from the cranial 
part of the adjacent somite to form one vertebra. While the vertebral body is composed of 
both somite halves, the development of proximal ribs and pedicles with transverse processes 
solely arises from the posterior somite compartment expressing Uncx4.1 (Leitges et al., 
2000). Cells of the center of the somite give rise to the intervertebral disc separating the 
vertebral bodies (Bagnall et al., 1988).  
An involvement of the Notch pathway in somitogenesis was first indicated by somite 
morphology defects observed in mice bearing targeted mutations in either the receptor Notch1 
(Conlon et al., 1995; Swiatek et al., 1994) or the major intracellular effector, RBPJκ (Oka et 
al., 1995). Notch signaling plays a fundamental role in the establishment of the antero-
posterior somite polarity and in the maintenance of somite borders during somitogenesis. 
Thus, mutations affecting Notch signaling components give rise to aberrant vertebral 
formation in mice and humans. 
1.2 The Notch signaling pathway 
The phylogenetically highly conserved Notch signaling pathway is an intercellular signaling 
system that has been described in a variety of metazoan organisms (Greenwald, 1998; 
  Introduction 
  5 
Gridley, 2003; Sherwood and McClay, 1997; Shi and Stanley, 2006; Weinmaster, 1997). It 
serves as a central regulator of fundamental developmental processes such as lateral 
inhibition, lineage decision and boundary formation, as well as in adult tissue homeostasis 
and regeneration (Conboy et al., 2003; Conboy and Rando, 2002; Ehebauer et al., 2006; 
Kohler et al., 2004; Nakamura and Chiba, 2007; Wilson and Radtke, 2006).  
Unlike most other paracrine cell signaling pathways Notch signaling represents juxtacrine 
signaling with receptors and ligands both being transmembrane proteins mediating 
communication of adjacent cells. A direct cell-cell contact allowing the binding of the 
receptor to its ligand is required for trans-signaling events (Fehon et al., 1990). Upon ligand 
binding, signal transduction is initiated and Notch receptors undergo complex proteolytic 
processes that eventually lead to the release of the intracellular domain of the receptor (Brou 
et al., 2000; Mumm et al., 2000; Schroeter et al., 1998). The intracellular transduction of 
Notch signals is remarkably simple and involves no secondary messengers. The liberated 
intracellular domain of Notch directly translocates to the nucleus to activate transcription of a 
wide array of downstream target genes (Kopan et al., 1996; Struhl and Adachi, 1998).  
During embryonic development Notch signaling plays a pivotal role in cell fate specifications 
(Artavanis-Tsakonas et al., 1999). The best understood effect of Notch signaling is the 
diversification of cell fates within a group of equivalent cells. A single cell expresses high 
levels of Notch ligand thereby activating Notch in the surrounding cells and inhibiting them 
from adopting the same fate. This Notch-mediated mechanism (termed lateral inhibition) 
governs, for instance, early neurogenesis in vertebrates and sensory hair cell formation in the 
vertebrate inner ear (Cabrera, 1990; Chitnis, 1995; de la Pompa et al., 1997; Muskavitch, 
1994). In other processes such as wing margin boundary formation in flies and somite 
segmentation in vertebrates, Notch-mediated lateral induction generates embryonic fields, 
domains of cells with the same fate (Lewis, 1998; Panin et al., 1997). Negative and positive 
feedback loops triggering down- and upregulation of Notch ligand expression in the signal-
receiving cells lead to these contrasting effects during organogenesis. 
1.3 Biochemistry of the canonical Notch signaling pathway 
Notch receptors (in mammals Notch1-4) are initially synthesized as ~300 kDa precursor 
proteins. Prior to their presentation on the cell surface, they are processed in the secretory 
pathway. The immature single-pass transmembrane precursor protein is subject to a first step 
of proteolytic processing by a furin-like convertase in the trans-Golgi network (Blaumueller et 
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al., 1997; Logeat et al., 1998). This first cleavage results in two fragments: a large 
extracellular segment (NECD) comprising a series of tandemly arranged EGF-like repeats and 
a smaller subunit that consists of a short ectodomain, the transmembrane domain and an 
intracellular domain (Fig. 1.3). The two subunits form a mature heterodimer by calcium-
dependent, non-covalent interactions within their extracellular regions preventing constitutive 
receptor activation in the absence of the ligand (Malecki et al., 2006).  
Multiple ligands, collectively known as DSL (Delta/Serrate/Lag-2) proteins, are known to 
elicit a signal through binding to the Notch receptor (Fehon et al., 1990; Henderson et al., 
Fig. 1.3: Notch signaling (Radtke et al., 2005). During their transport to the cell surface Notch receptors are 
cleaved by a Furin-like convertase and modified by Fringe glycolsyltransferases. Upon ligand interaction with 
the heterodimeric Notch receptor, signal transduction is initiated involving two sequential proteolytic cleavages. 
The first - within the Notch extracellular domain - is mediated by the metalloprotease TACE. The endocytosis of 
the extracellular subunit of the receptor by the neighbouring ligand-expressing cell facilitates this event. The 
second cleavage occurs within the Notch transmembrane domain and is mediated by the γ-secretase activity of a
multi-protein complex of presenilins (PS). The released intracellular domain of Notch (NICD) translocates to the 
nucleus and binds to the transcription factor CSL. This interaction leads to transcriptional activation by 
displacement of corepressors (CoR) and simultaneous recruitment of coactivators (CoA), including mastermind-
like proteins (MAML1). 
  Introduction 
  7 
1994; Thomas et al., 1991; Vassin and Campos-Ortega, 1987). In mammals, five DSL 
proteins have been described that are classified in two distinct families: homologues of the 
Drosophila Delta protein (Dll1 (Delta-like1), Dll3 and Dll4) and homologues of the 
Drosophila Serrate protein (Jagged1 and Jagged2) (Bettenhausen et al., 1995; Dunwoodie et 
al., 1997; Lindsell et al., 1995; Shawber et al., 1996a; Shutter et al., 2000).   
In response to ligand binding, E3 ubiquitin-ligases trigger endocytosis of the ligand-NECD 
complex by the ligand-presenting cell resulting in a physical dissociation of the Notch 
heterodimer (Itoh et al., 2003; Lamar et al., 2001; Nichols et al., 2007; Parks et al., 2000; 
Pavlopoulos et al., 2001). The removal of the extracellular subunit of Notch leads to a 
conformational change in the membrane-tethered Notch derivative NEXT (Notch 
extracellular truncation). In consequence, a second cleavage site is exposed within the 
extracellular juxtamembrane region. It is recognized by the metalloprotease TACE (Tumor 
necrosis factor-alpha converting enzyme), belonging to the group of ADAM (a desintegrin 
and metalloprotease) enzymes that catalyzes shedding of the ectodomain (Brou et al., 2000; 
Mumm et al., 2000). 
Subsequently, a third cleavage termed regulated intramembrane proteolysis (RIP) occurs 
within the transmembrane domain due to the γ-secretase activity of a proteolytic multi-protein 
complex consisting of the core components presenilin, nicastrin, APH1 (anterior pharynx 
defective1) and PEN2 (Presenilin enhancer 2) (Brown et al., 2000; Schroeter et al., 1998; 
Wolfe, 2006). It was suggested that the ubiquitination of Notch and its targeting to an 
endocytic vesicle is a prerequisite for the γ-secretase cleavage of Notch (Gupta-Rossi et al., 
2004). Interestingly, the presenilin/γ-secretase complex also mediates the proteolytic cleavage 
of amyloid precursor protein (APP) that is involved in Alzheimer disease (Borchelt et al., 
1996; Duff et al., 1996; Price et al., 1998). 
The intracellular domain of Notch (NICD) contains a nuclear localization sequence and – 
after release from the cell membrane - undergoes translocation into the nucleus where it forms 
a short-lived complex with the major Notch effector, the DNA-binding transcriptional 
repressor CSL (CBF1 in human, Suppressor of hairless in D. melanogaster, LAG-1 in C. 
elegans and RBPJκ in mice) (Jarriault et al., 1995; Shawber et al., 1996b). In the absence of 
NICD, CSL forms a multiprotein transcriptional repressor complex together with corepressors 
such as SMRT (silencing mediator of retinoic and thyroid receptors), N-CoR (nuclear receptor 
corepressor) and CIR (CBF1 interacting corepressor) (Lai, 2002).  
Upon CSL-binding NICD acts as a transcriptional coactivator by displacing the CSL-
dependent corepressor complex including the histone deacetylase HDAC-1 which converts 
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local chromatin into a transcriptionally silent form (Kao et al., 1998). Additionally, NICD 
promotes the recruitment of transcriptional coactivators (Jeffries et al., 2002) such as the p300 
histone acetyltransferase (HAT) complex (Oswald et al., 2001; Rand et al., 2000) and the 
Mastermind-like protein/LAG-3/SEL-8 (Nam et al., 2006; Wilson and Radtke, 2006), a 
scaffold protein for the formation of a large multiprotein transcriptional activation complex 
that facilitates the activation of lineage-specific programs of gene expression. Known direct 
target genes of Notch include members of the hairy/enhancer-of split (HES), HES-related 
(HERP) and Mesoderm posterior (MESP) families of basic helix-loop-helix transcription 
factors as well as Lfng (Cole et al., 2002; Jarriault et al., 1995; Jouve et al., 2000; Kageyama 
et al., 2007; Maier and Gessler, 2000; Morales et al., 2002; Morimoto et al., 2005; Takahashi 
et al., 2000). Other targets include CyclinD1, Ephrin B2, Nodal, Myc and smooth muscle 
alpha actin (Klinakis et al., 2006; Krebs et al., 2003; McDaniell et al., 2006; Noseda et al., 
2004; Ronchini and Capobianco, 2001). 
In the majority of developmental settings, signals are induced via the conserved canonical 
Notch signaling pathway described above. However, although poorly understood, there is 
evidence for alternative actions, for instance DSL-ligand independent Notch signaling, CSL-
independent signaling or Notch-independent CSL auto-activation (Barolo et al., 2000; 
Matsuno et al., 1997; Rusconi and Corbin, 1999; Shawber et al., 1996b).  
1.4 Modulation of Notch signaling 
Although the core of the Notch pathway is remarkably simple employing only three 
components, a ligand, a receptor and a transcription factor, signal transduction is embedded in 
a complex network of modulatory processes (Bray, 2006). Moreover, tissue-specific 
combinations of Notch modulators may contribute to different modes of regulation. 
Therefore, the effects on Notch signaling always depend on the cellular context and the 
available protein network. Regulation takes place at several levels of the Notch pathway: on 
the level of availability and affinity of ligands and receptors previous to signal transduction 
and after initiation of the signal by endocytosis and removal of bound protein. A third level of 
modulation includes the stability of the Notch intracellular domain (ICD) and its enhancer 
complex and the expression of modulators that act downstream of the Notch signal.  
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1.4.1 Regulation of Notch ICD turnover and negative feedback loops of 
Notch targets 
Notch-mediated transcription is an extremely dynamic process. Rapid proteolytic turnover of 
Notch ICD and a short half life of the enhancer complex ensure a high sensitivity of the Notch 
signaling pathway. 
The recruitment of negative regulators by the scaffold protein MAML facilitates the 
hyperphosphorylation of Notch ICD eventually leading to its proteasomal degradation (Foltz 
et al., 2002; Fryer et al., 2002; Qiu et al., 2000). 
The cytoplasmic protein Deltex acts as a transcriptional regulator of Notch signaling by 
interacting with Notch ICD independent of CSL proteins (Matsuno et al., 1998; Matsuno et 
al., 2002; Yamamoto et al., 2001). The modulatory effect of Deltex on Notch signaling 
depends on the cellular context (Izon et al., 2002). It involves targeting Notch ICD to the late 
endosomes where it accumulates, although the exact mechanism of this process is still unclear 
(Hori et al., 2004). Deltex proteins are not expressed in the PSM and the somites but are 
thought to be involved in cytodifferentiation of neuronal tissues and in cell proliferation 
events in the eye, in vascular structures and during hematopoiesis (Mitsiadis et al., 2001) 
Transcripts of Nrarp (Notch-regulated ankyrin repeat protein), a transcriptional target of 
Notch signaling, are detected in the paraxial mesoderm. Nrarp functions as a feedback 
regulator of Notch signaling that attenuates ICD-mediated transcription by direct interaction 
with Notch and the CSL protein CBF-1 (Krebs et al., 2001; Lamar et al., 2001; Yun and 
Bevan, 2003). 
Similarly, the Notch target gene Mesp2, encoding a transcription factor, establishes a 
feedback loop by suppressing Notch activity through induction of the Lunatic fringe gene 
(Morimoto et al., 2005). Mesp2 is involved in the specification of somite polarity. It is 
expressed in the rostral presomitic mesoderm and becomes immediately down-regulated after 
the formation of the segmented somites (Saga et al., 1997). 
Other modulators of Notch (such as numb and numb-like) have important roles in somite 
maturation and in neural development (Holowacz et al., 2006). These proteins exert their 
function by promoting Notch degradation and recruitment into endocytic vesicles (McGill and 
McGlade, 2003). 
1.4.2 Processes modulating Notch receptors and ligands 
Glycosylation of the extracellular domain of Notch modulates the sensitivity of Notch 
receptors for their ligands. In addition, fine-tuning of the signaling intensity of Notch can be 
  Introduction 
  10 
achieved by inhibitory associations of the Notch receptor with coexpressed ligands and effects 
on endocytosis rates. Moreover, the observed formation of homomultimers of Notch receptors 
and ligands might contribute to the modulation of Notch activity (Sakamoto et al., 2005). 
Glycosylation of Notch receptors and ligands 
The affinity of Notch receptors for their ligands is regulated by the glycosyltransferases Pofut 
(protein o-fucosyltransferase) and Fringe that participate in the synthesis of O-fucose glycans 
attached to EGF repeats in the Notch receptor (Haines and Irvine, 2003; Haltiwanger and 
Lowe, 2004; Moloney et al., 2000a).  
O-fucosylation occurs in the endoplasmatic reticulum (ER) at specific serine or threonine 
residues in a consensus sequence of certain EGF repeats and is catalyzed by Pofut1 (Okajima 
et al., 2003; Panin et al., 2002). In the Golgi network, the elongation of O-fucose to a 
tetrasaccharide requires the β-1,3N-acetylglucosaminyl-transferase activity of proteins 
encoded by Fringe genes (in mammals: Lunatic fringe, Maniac fringe and Radical fringe). 
Glycosylation of EGF repeat 12 in the Notch receptor differentially alters Notch affinity for 
its ligands (Lei et al., 2003; Rampal et al., 2005; Shao et al., 2003). For example, 
glycosylation by Lfng exerts a positive impact on Delta-Notch signaling whereas it negatively 
affects the association of the Notch ligand Serrate and Notch (Bruckner et al., 2000; Fleming 
et al., 1997; Hicks et al., 2000; Klein and Arias, 1998; Moloney et al., 2000b; Panin et al., 
1997). The weakened ligand-receptor interaction no longer effectively promotes Notch 
proteolysis which is required for activation of downstream signaling events (Yang et al., 
2005). Therefore Serrate-Notch signaling intensity is diminished by the action of Fringe. 
Similar to the Notch receptor, consensus sites for O-fucosylation exist in the EGF-like repeats 
of Notch ligands. Studies in Drosophila have identified a hypomorphic allele of Delta (sup5) 
which exhibits a mutation in the O-fucosylation site in EGF3 (Lieber et al., 1992). 
Additionally, a missense mutation resulting in the human disorder Alagille syndrome maps to 
a predicted O-fucose site in EGF-like repeat 5 of Jagged1 (Heritage et al., 2000). These 
observations provide evidence that O-fucosylation is essential for normal ligand function. 
Although the exact functional significance of these modifications of Notch ligands is still not 
known, it was suggested that O-fucosylation might facilitate ligand multimerization (Panin et 
al., 2002). 
Loss of Pofut activity in mice leads to embryonic lethal phenotypes that resemble the 
complete absence of Notch signaling indicating that O-fucosylation is absolutely required for 
signaling through all Notch receptors (Shi and Stanley, 2003). In contrast to the essential role 
of Pofut in all contexts, Fringe activity has a rather modulatory effect on Notch signaling in 
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only a subset of Notch functions (Okajima et al., 2003). Loss of Lunatic fringe (Lfng) activity 
causes a less severe phenotype compared to that of Pofut mutant mice. Lfng mutant mice 
show irregular shaped somites with disturbed antero-posterior polarity and truncation of the 
antero-posterior axis both in the trunk and tail (Zhang and Gridley, 1998).  
Ubiquitination, endocytosis and multimerization of Notch ligands 
Several reports highlight the importance of internalization of Notch ligands and receptors for 
the regulation of the Notch signal (reviewed in Le et al., 2005). Drosophila shibire (dynamin) 
mutants that are endocytosis-deficient were used to demonstrate that dynamin-dependent 
endocytosis is required for efficient Notch signaling (Seugnet et al., 1997). Internalization of 
the ligand-receptor complex leads to a dissociation of the Notch heterodimer and subsequent 
removal of the Notch extracellular domain (NECD) which is a prerequisite for Notch 
ectodomain shedding and Notch activation (Nichols et al., 2007). Additionally, the endocytic 
process might be important for clearing bound ligands from the surface and re-sensitizing the 
cell for new Notch signals. It was suggested that ligand-NECD complexes dissociate in an 
endocytic vesicle and unbound Delta protein returns to the surface via recycling vesicles 
while NECD is retained internally and eventually destroyed (Chitnis, 2006). Wang and Struhl 
proposed that Notch ligands need to be targeted by mono-ubiquitination in order to enter 
specific endocytic recycling compartments as a prerequisite for their conversion into active 
ligands (Wang and Struhl, 2004; Wang and Struhl, 2005). Moreover, it was suggested that 
endocytosis and recycling may promote clustering of the Notch ligands in special 
microdomains at the cell surface thus enhancing Notch signaling (Chitnis, 2006). 
1.5 Pathology of aberrant Notch signaling 
In humans aberrant Notch signaling has been linked to numerous developmental 
abnormalities and pathologies. For instance, mutations in the Notch1 receptor can cause aortic 
valve disease (Garg et al., 2005). A small subset of patients with Alagille syndrome (a 
congenital syndrome associated with liver, cardiovascular, and skeletal defects), normally 
associated with mutations of the Notch ligand Jagged1, shows alterations in the Notch2 gene 
(Li et al., 1997; McDaniell et al., 2006; Oda et al., 1997). The congenital vascular disorder 
CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and 
Leucoencephalopathy) is caused by missense mutations in the Notch3 gene and associated 
with stroke and dementia (Joutel et al., 1996; Joutel et al., 1997). Patients suffering from 
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spondylocostal dysostosis display multiple vertebral segmentation defects and rib anomalies 
caused by mutations of the Notch ligand Dll3. 
Notch signaling can affect tumorigenesis, e.g. by acting as an oncogene in T-cell acute 
lymphoblastic leukemia (T-ALL) which arises from a mutation in the Notch1 gene that 
renders the receptor more susceptible to activation (Ellisen et al., 1991; Malecki et al., 2006; 
Radtke and Raj, 2003; Weng and Lau, 2005). Aberrant Notch4 signaling in mammary 
epithelial cells promotes the development of tumors in the mammary gland (Jhappan et al., 
1992; Politi et al., 2004). On the other hand, Notch signaling is reduced in several cancers 
pointing to a potential function as a tumor suppressor dependent on the cellular context (Miele 
et al., 2006; reviewed in Radtke and Raj, 2003). For instance, deletion of Notch1 in the 
epidermis results in the development of skin tumors (Nicolas et al., 2003).  
1.6 Components of the Notch signaling pathway 
While receptors and ligands participating in Notch signaling were found as several 
homologues in mammals, signal transduction through all Notch receptors seems to use the 
same basic signaling pathway via one major downstream effector. In mice, this function is 
exerted by the highly conserved and ubiquitously expressed CSL transcription factor, RBPJκ. 
Mice carrying RBPJκ null alleles show severe phenotypes due to a complete loss of Notch 
signaling (Oka et al., 1995). 
1.6.1 Notch receptors 
Ninety years ago, in 1917, Thomas Hunt Morgan described a mutant strain of the fruit fly 
Drosophila melanogaster that exhibited notches at the margins of the wing blades (Morgan, 
1917). This trait was attributed to a partial loss of function (haploinsufficiency) of a gene 
from the neurogenic “notch” locus (Mohr, 1919) encoding a membrane-spanning receptor 
with EGF-like repeats that was cloned in the mid-1980’s (Kidd et al., 1986; Wharton et al., 
1985). 
Four Notch genes (Notch1-4) have been identified in mammals. Among these homologues, 
Notch1 is probably the best studied member of the receptor family because of its involvement 
in a great variety of developmental processes during embryogenesis (reviewed in Bolos et al., 
2007; Chiba, 2006; Weinmaster and Kintner, 2003). The Notch1 gene is expressed in 
derivatives of all three germ layers during early mouse development, including the primitive 
streak during gastrulation, the presomitic mesoderm during the process of somitogenesis, 
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differentiating endothelial cells and the developing nervous system (Lieber et al., 1992; 
Reaume et al., 1992).  
Notch1 plays a vital role in postimplantation development as Notch1 mutant mice die during 
embryogenesis around embryonic day 9.5 with vascular and somite defects (Conlon et al., 
1995; Huppert et al., 2000; Krebs et al., 2000; Swiatek et al., 1994). Notch1 and Notch2 are 
both required for embryo viability. They are expressed in an overlapping pattern in the 
presomitic mesoderm and null alleles lead to severe defects in somite patterning emphasizing 
the importance of Notch signaling during somitogenesis (Krebs et al., 2000; Shimizu et al., 
1999; Swiatek et al., 1994). Ablation of Notch3 or Notch4 does not lead to aberrant 
embryonic phenotypes (Krebs et al., 2000; Krebs et al., 2003). 
Regarding the protein structure of Notch receptors (Fig. 1.4), the extracellular domains 
comprise multiple tandem-arrayed epidermal growth factor (EGF)-like repeats, three 
Fig. 1.4: Notch receptors and ligands (adapted from Niessen and Karsan, 2007). Mammals have four Notch 
receptors (Notch1–4) and five ligands [Jagged1/2, Delta-like (Dll)-1/3/4]. Notch receptors form heterodimers. In 
their extracellular domain they contain several epidermal growth factor (EGF)-like repeats, three Lin-12/Notch 
(LNR) repeats, and a heterodimerization domain that stabilizes Notch heterodimer formation through calcium-
dependent interactions. The intracellular domain comprises an RBPJκ-associated molecule (RAM) domain, 
seven ankyrin (ANK) repeats, two nuclear localization signals (NLS), a transactivation domain (TAD), and a 
PEST domain. Notch ligands are also single-pass transmembrane proteins. The extracellular domains consist of a 
Delta/Serrate/Lag2 (DSL) domain unique to Notch ligands and multiple EGF-like repeats. Jagged proteins 
contain an additional cysteine-rich domain and a von Willebrand factor type C domain. The intracellular 
domains of Jagged1, Dll1 and Dll4 have been shown to contain PDZ binding motifs. 
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Lin12/Notch (LNR) motifs and a heterodimerization domain. The EGF-like repeats govern 
calcium-dependent ligand-binding and promote homodimerization of the receptor. EGF-like 
repeats 11 and 12 of Drosophila Notch alone are necessary and sufficient to mediate 
interactions with Notch ligands (Rebay et al., 1991). Some EGF-like repeats are glycosylated 
at O-fucosylation sites by Pofut and Fringe resulting in differential affinity for Notch ligands 
(see chapter 1.4.2; Hicks et al., 2000). The LNR motifs are responsible for heterodimerization 
and prevent receptor activation in the absence of receptor-ligand engagement (Fehon et al., 
1990; Greenwald and Seydoux, 1990; Rand et al., 2000; Sakamoto et al., 2005; Sanchez-
Irizarry et al., 2004).  
The intracellular domain of Notch that mediates Notch signaling carries the RBPJκ associated 
molecule (RAM) domain close to the single-pass transmembrane domain and seven ankyrin 
repeats flanked by two nuclear localization signals. The RAM domain and the ankyrin repeats 
interact with the CSL transcription factor in the nucleus (Beatus et al., 2001; Tamura et al., 
1995). In addition, Notch ICD contains a PEST (proline-glutamate-serine-threonine rich) 
sequence involved in regulating protein half-life and, except for Notch4, a transactivation 
domain (TAD) (Beatus et al., 2001; Fryer et al., 2004). The TAD domain recruits 
transcriptional activators such as Mastermind-like and the histone acetyltransferase (HAT) 
complex (Kurooka et al., 1998; Tani et al., 2001). 
1.6.2 Notch ligands  
Three of the five Notch ligands described in mammals are expressed in the presomitic 
mesoderm, namely Dll1, Dll3 and Jagged1. Dll1 and Dll3 are both essential for proper somite 
formation, indicated by severe somite defects in mutant mice, whereas Jagged1 mutant mice 
show no somitic phenotype (Dunwoodie et al., 2002; Hrabe De et al., 1997; Xue et al., 1999). 
Jagged1 and Dll4 play vital roles in vascular development and remodeling, whereas Jagged2 
participates mainly in limb, craniofacial, and thymic development (Jiang et al., 1998; Krebs et 
al., 2004; Valsecchi et al., 1997; Xue et al., 1999).  
For all ligands, except for Dll3, a clear Notch activating function was demonstrated (Hicks et 
al., 2000; Lindsell et al., 1995; Shawber et al., 1996a; Shimizu et al., 2000a; Shutter et al., 
2000). Apart from their positive function, Notch ligands were shown to act in a dominant-
negative manner and impair signal transduction when expressed at high levels in the same cell 
as Notch (cis-inhibition; de Celis and Bray, 2000; Dunwoodie et al., 1997; Jacobsen et al., 
1998; Sakamoto et al., 2002). The associated mechanism is not known but it appears to be 
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required, for instance, during wing development of flies by limiting Notch activation to a 
defined domain at the wing margin (Micchelli et al., 1997).  
Notch ligands are type I transmembrane proteins that share several structural features 
(Fig. 1.4). All Notch ligands have a DSL domain at the N terminus, a variable number of 
multiple epidermal growth factor (EGF)-like repeats with distinctive spacing of the six 
conserved cysteine residue in the extracellular domain and a relatively short cytoplasmic tail 
(Fleming et al., 1990; Nye and Kopan, 1995). The DSL domain unique to Notch ligands 
shows similarities to the EGF-like repeats and is indispensable for Notch activation through 
binding to EGF-like repeats 11 and 12 of the Notch receptor (Shimizu et al., 1999; Shimizu et 
al., 2000a; Tax et al., 1994). The EGF-like repeats contribute to stable ligand-receptor 
interaction and homodimerization and are substrates for glycosylation (Panin et al., 2002; 
Rebay et al., 1991; Sakamoto et al., 2005). 
Jagged proteins are characterized by an additional cysteine-rich domain in the extracellular 
domain and a von Willebrand factor type C domain. The cysteine-rich domain is thought to 
control Notch receptor specificity while the latter seems to be involved in ligand dimerization 
(Fleming, 1998). 
The intracellular region of the Notch ligands is assumed to have a rather disordered nature 
without any known structural domains. Different ligand types show distinct cytoplasmic tails 
while within the same ligand type the ICD sequence is evolutionary well conserved (Pintar et 
al., 2007). Recent reports suggest that, in addition to allowing regulated endocytosis (see 
chapter 1.4.2), the intracellular domain of some Notch ligands seem to function as 
transcriptional regulators. Similar to Notch receptors, some Notch ligands are prone to 
successive ADAM protease and γ-secretase cleavages that release the intracellular domain 
(LaVoie and Selkoe, 2003; Six et al., 2003). Putative nuclear localization sequences were 
found in all Notch ligands except for DLL3 and DLL4. The intracellular moiety of DLL1 was 
detected in the cell nucleus and interaction with nuclear factors was demonstrated (Hiratochi 
et al., 2007; Ikeuchi and Sisodia, 2003; Six et al., 2003). These results suggest that DLL1 ICD 
contributes to the activation of transcriptional events indicating that Notch signaling might not 
be exclusively unidirectional.  
The importance and properties of the cleaved extracellular domain of DLL1 is still not known. 
In D. melanogaster the Delta protein exists in transmembrane and soluble, truncated forms 
generated by the cleavage by an ADAM metalloprotease (Klueg et al., 1998; Qi et al., 1999). 
In C. elegans there is evidence that secreted DSL proteins act as natural ligands and can 
substitute for membrane-tethered ligands (Chen et al., 2004). 
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Additionally, the intracellular domains of DLL1, DLL4 and Jagged1 carry a PDZ (Post-
synaptic density-95/Discs large/Zonula occludens-1) ligand binding motif at the C-terminal 
end (Sheng and Sala, 2001). Recently, it has been shown that several scaffold proteins of the 
MAGUK (Membrane-Associated Guanylate Kinase) family interact with the C-terminus of 
DLL1 and DLL4 and that a deletion of the class I PDZ binding motif ATEV in DLL1 
abolishes interaction with MAGUK protein family members (Pfister et al., 2003; Six et al., 
2004). A zebrafish DeltaD variant that fails to bind PDZ- containing proteins functions 
normally as a Notch ligand (Wright et al., 2004). Thus, the initiation of the ligand-induced 
Notch signal seems to be independent of this novel PDZ-dependent signaling mechanism 
inside the ligand expressing cell suggesting a cell-autonomous function of the Notch ligands 
DLL1 and Jagged1 (Ascano et al., 2003; Six et al., 2004).  
Whereas Jagged1 exhibits a class II PDZ binding motif which was shown to interact with the 
ras-binding protein Afadin (AF6) (Ascano et al., 2003; Hock et al., 1998) the C-termini of 
DLL3 and Jagged2 do not contain any PDZ binding motif emphasizing the differences of the 
Notch ligands with respect to their interactions with other proteins. 
Delta-like 1 (DLL1) 
Mutations in Delta were initially described by Dexter (1914) on the basis of wing venation 
defects observed in a Drosophila melanogaster strain heterozygous for a loss-of-function 
mutation in the Delta gene. The Delta homologue, Delta-like 1 (Dll1), is probably the best 
studied Notch ligand in vertebrates. The DLL1 protein of vertebrates contains a DSL domain 
and eight EGF-like repeats in its extracellular domain. The DLL1 intracellular domain is 
lysine-rich and carries a PDZ ligand binding motif at its C-terminal end. 
Dll1 is expressed during gastrulation and early organogenesis in a spatiotemporal-restricted 
manner in the presomitic and somitic mesoderm, in the nervous system and the spinal nerves 
(Bettenhausen et al., 1995; Jouve et al., 2000). Dll1 mRNA expression in the paraxial 
mesoderm starts with the onset of gastrulation (E7) and continues until day 12.5 of murine 
development correlating with the period of somitogenesis (Beckers et al., 1999). During this 
period strong mRNA expression is detected in the whole presomitic mesoderm. In the formed 
somites Dll1 expression is restricted to the caudal halves. Additionally, Dll1 transcripts were 
detected at later stages in epithelial ducts of several organs, in skeletal and smooth muscles, 
the central nervous system, some sensory epithelia as well as in endothelial cells of blood 
vessels (Beckers et al., 1999). 
During somitogenesis Dll1 is required for the epithelialization of the somites and for the 
maintenance of somite borders (Hrabe De et al., 1997). In the nervous system Dll1 
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participates in cell fate decisions and maintains cells in an undifferentiated state by inducing 
Notch signals (Chitnis, 1995; Lewis J, 1998). 
Mice heterozygous for the Dll1 null allele display subtle malformation of the vertebrae 
indicating a haploinsufficiency of Dll1 (Cordes et al., 2004). Homozygous Dll1 mutant 
embryos exhibit severe patterning defects in the paraxial mesoderm and a hyperplastic central 
nervous system. Albeit an initial metameric unit is formed, somites are not fully epithelialized 
and their borders are not maintained leading to a perturbed arrangement of myotomes and 
sclerotomes. Lfng expression in the PSM is severely downregulated and in consequence the 
segments lack any detectable antero-posterior polarity as indicated by contiguous Tbx18 
expression and the loss of Uncx4.1 expression, both representing somite polarity markers 
(Bussen et al., 2004; Hrabe De et al., 1997; Morales et al., 2002). Dll1-deficient mice die 
around E12 from severe hemorrhagic bleedings as a secondary effect due to vascular defects. 
Delta-like 3 (DLL3), a divergent DSL protein 
The Delta-like 3 (Dll3) gene was isolated by a subtracted library screen as a gene expressed in 
the mesoderm and the primitive streak during gastrulation (Dunwoodie et al., 1997). It was 
the third member of the Delta familiy identified in vertebrates. So far, the second homologue 
Delta2 found in vertebrates has only been described in Xenopus laevis (Mansouri et al., 1997) 
whereas Dll3 has only been identified in mammals and is the most divergent ligand among 
the Delta homologues. DLL3 protein exhibits 6 EGF-like repeats and a highly modified DSL 
domain. The intracellular domain of DLL3 bears no homology to other DSL ligands, is about 
half their size and contains neither nuclear localization signals nor a PDZ binding motif at its 
C-terminus. As DLL3 ICD lacks lysine residues, it is unlikely to be ubiquitinylated and 
internalized via endocytosis. 
Dll3 shows a diverse and dynamic pattern of mRNA expression during gastrulation and early 
organogenesis. Dll3 transcripts localize to the primitive streak and later, at early somite 
stages, persist in the tail bud. The highest level of Dll3 transcripts is found in the paraxial 
mesoderm. Expression is also detected along the length of the presomitic mesoderm and in 
the nascent somites but ceases as somites mature. Dll3 is expressed in a broad band in the 
forming somite and in the anterior half of the nascent somites (Dunwoodie et al., 1997). 
Additionally, lower levels of Dll3 mRNA were described in the neuroectoderm and in the 
pituitary (Dunwoodie et al., 1997; Raetzman et al., 2004).  
Analysis of Dll3 null mutant embryos generated by gene targeting (Dunwoodie et al., 2002) 
and of the radiation induced Dll3 pudgy mouse mutant (Kusumi et al., 1998) revealed an 
essential role of this gene in somite formation and skeletogenesis. In pudgy mice, a frame-
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shift caused by a four-nucleotide deletion leads to an early truncation of the expected Dll3 
product prior to its DSL domain (Grüneberg, 1961; Kusumi et al., 1998). The loss-of-function 
mutations in the Dll3 gene result in a highly disorganized vertebrocostal skeleton (Grüneberg, 
1961). The developmental origin of these defects is a delayed and irregular somite formation. 
This results in the perturbation of antero-posterior somite polarity revealed by a salt and 
pepper expression pattern of the polarity marker Uncx4.1 and fuzzy expression of the anterior 
compartment marker Tbx18 (Bussen et al., 2004; Takahashi et al., 2003). The expression of 
Notch target genes as Lfng, Hes1, Hes5 and Hey1 is disrupted in the presomitic mesoderm of 
these mice (Dunwoodie et al., 2002). Additionally, histological analyses of Dll3 mutant 
embryos revealed a neural phenotype with incomplete penetrance. Whereas the neural tube of 
the trunk showed no defects, Dll3 mutant mice appear to have an enlarged roof to the fourth 
ventricle of the brain with a reduction or absence of the neuroepithelium and malformations in 
the lateral ventricles (Kusumi et al., 1998; Sparrow et al., 2002).  
Dll3 is essential for proper somitogenesis but dispensable for embryo vitality. Homozygous 
pudgy mice are viable although loss of homozygous pudgy progeny has been observed before 
E9.5 (Dunwoodie et al., 2002; Kusumi et al., 1998). 
Numerous mutations of DLL3 protein have been reported in SCD (spondylocostal dysostosis) 
patients, all appearing to be pure loss-of function mutations either leading to premature 
translational termination with subsequent loss of important protein domains such as EGF-like 
repeats and/or the transmembrane domain or to cause missense or insertion mutations 
(Turnpenny et al., 2003).  
Contradicting evidence on Dll3 function exists in the literature. Dunwoodie et al. (1997) 
showed that Dll3 can inhibit primary neurogenesis when ectopically expressed in Xenopus 
leavis, whereas Ladi et al. (2005) demonstrated the opposite effect in a similar experiment. 
Thus, different potential functions have been suggested: Dll3 might act as a bona fide Notch 
ligand activating Notch signaling as demonstrated for the other Notch ligands. Alternatively, 
it might have a rather antagonistic function or act as a modulator of Notch signaling 
(Dunwoodie et al., 1997; Ladi et al., 2005; Weinmaster and Kintner, 2003). 
 
  Introduction 
  19 
Divergence of Dll3 from Dll1 and other homologues 
In the mouse embryo Dll1 and Dll3 expression patterns overlap in the posterior PSM and are 
distinct in the anterior PSM and the somites (Fig. 1.5). In the forming somites, Dll1 
expression coincides with the posterior half, while Dll3 is expressed in the anterior half. 
Additionally, Dll1 is expressed in the posterior halves of the already formed somites. 
Dll1 and Dll3 are both essential for normal somite formation and for correct specification of 
the antero-posterior segment polarity within the presomitic mesoderm (Dunwoodie et al., 
2002; Hrabe De et al., 1997). However, null mutant mice display clearly distinct phenotypes. 
Loss-of-function mutations of the two DSL proteins differently influence segment polarity 
and activation of downstream targets. In Dll1 mutant embryos expression of the posterior 
somite marker Uncx4.1 is totally lost whereas in Dll3 pudgy embryos Uncx4.1 shows a 
random expression pattern. Expression of the Notch target genes Lfng and Hes1 is severely 
downregulated or absent in Dll1 null mutants while in Dll3 null embryos the caudal 
expression domain of these genes is completely lost but the rostral stripe is retained 
(Barrantes et al., 1999; Jouve et al., 2000).  
In addition to the distinct phenotypes of their null mutants, the DSL proteins DLL1 and DLL3 
differ significantly in their amino acid sequences. DLL1 and DLL3 proteins share only 36% 
overall amino acid identity. The highest homology of DLL1 and DLL3 exists between EGF-
like repeat 4 of DLL3 and repeat 6 of DLL1 (63%). Compared to DLL1 and other Delta 
homologues, the DLL3 extracellular domain contains an almost unrecognizable DSL domain 
and only six EGF-like repeats with altered spacing between some of them. Based on DLL1-
sequence homology, DLL3 lacks EGF-like repeat 2 (and 3), which is a perfectly conserved 
EGF-like repeat among DSL proteins in vertebrates and D. melanogaster (Lissemore and 
Fig. 1.5: mRNA expression of Dll3 and Dll1 in 
mouse presomitic mesoderm (Dunwoodie et al., 
1997). In situ hybridization of tail halves: Dll3
(top) is expressed in a broad band at the anterior of 
the forming somite (short thick black line); at the 
anterior part of the nascent somite this expression 
is refined to a faint narrow band (black arrowhead). 
Dll1 (bottom) is expressed in a broad band at the 
posterior end of the forming somite (white line); in 
the formed somites Dll1 expression is restricted to 
the posterior half (white arrowhead). 
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Starmer, 1999). The DSL domain of DLL3 displays only 18% amino acid identity with the 
DLL1 DSL domain compared to 51% identity between the DSL domains of DLL4 and DLL1. 
Additionally, conserved motifs present in the DSL domains of all other Notch ligands are 
absent in DLL3. Furthermore, the intracellular domains of DLL1 and DLL3 are highly 
dissimilar. While the DLL1 ICD comprises lysines and a C-terminal PDZ domain, DLL3 
lacks both features. 
DLL1 was unambiguously proven to be a bona fide Notch ligand whereas there are few 
reports on DLL3 function, some of them with contradictory results (Dunwoodie, 2002; Ladi, 
2005). Based on these observations a hypothesis was put forward suggesting that Dll1 and 
Dll3 have non-redundant functions and that their functional non-equivalence is due to 
differences in protein structure and sequence.  
Redundancy of Notch ligands 
Some Notch ligands might have redundant functions. Due to the distinct expression patterns 
of the ligands in the mouse embryo a biochemical redundancy might not be revealed in null 
mutant mice. Experiments in C. elegans, D. melanogaster and mice have shown that Notch 
ligands may be interchangeable and exert partially redundant functions depending on the 
cellular context. Although in C. elegans the Notch ligands Lag-2 and APX-1 have a relatively 
low level of homology and their mutants show different phenotypes, APX-1 expressed under 
the Lag-2 promotor can fully substitute for the loss of Lag-2 in the nematode (Fitzgerald and 
Greenwald, 1995; Gao and Kimble, 1995). Similarly, Serrate expression can functionally 
replace Delta activity during neuroblast segregation in the Drosophila embryo (Gu et al., 
1995). In cell fate specification in the Drosophila sensory organ lineage Delta and Serrate 
have redundant functions required for asymmetric cell divisions (Zeng et al., 1998). Nobta et 
al. (2005) showed that during osteoblastic differentiation in mice Dll1 and Jagged1 are 
functional redundant as they induce an identical cellular response. For Dll1 and Dll3, 
functional redundancy was proposed in some cellular contexts such as the spinal cord and the 
melanotrope lineage in the pituitary gland where Dll1 and Dll3 are coexpressed as loss of Dll3 
did not lead to any phenotype in these tissues (Raetzman et al., 2004).  
Nevertheless, some developmental processes employ different ligands for distinct signaling 
events. In the inner ear of the mouse DLL1 and Jagged1 were found to have rather contrasting 
functions (Brooker et al., 2006). While DLL1 mediates the function of Notch in lateral 
inhibition, Jagged1 is responsible for activating the prosensory function of Notch. 
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2 Aims of this study 
The DSL proteins DLL1 and DLL3 are both essential for somitogenesis and were originally 
thought to constitute activating Notch ligands. However, despite the largely overlapping 
expression pattern of Dll1 and Dll3, null alleles of both genes result in different phenotypes 
and both proteins differ with respect to various protein domains. The distinct phenotypes of 
mutant embryos and the structural divergence of the proteins suggested that DLL1 and DLL3 
are functionally non-equivalent Notch ligands. Experiments in D. melanogaster and C. 
elegans revealed functional reduncancy of Notch ligands in certain contexts. The objectives of 
this study were to evaluate the biochemical equivalence and to elucidate the biochemical 
differences of the mouse homologues DLL1 and DLL3.  
Towards these aims, an in vitro comparison of Dll1 and Dll3 and chimeric proteins with 
respect to transactivation potential, cell surface presentation and subcellular localization was 
devised to reveal potential differences in the biochemical properties of the protein domains. In 
order to analyze the biochemical equivalence of the two DSL proteins in vivo it was planned 
to replace Dll1 with Dll3 coding sequence by homologous recombination.  
Additionally, since the DSL domain of Notch ligands was previously shown to be essential 
for Notch binding (Shimizu et al., 1999), the significance of conserved sequences in the DSL 
domain of DLL1 not present in DLL3, was addressed by mutating these sequences in the 
DLL1 protein and analyzing the effect of these mutations with regard to Notch transactivation 
and protein localization.  
Is summary, these experiments should help to clarify the significance of the divergent protein 
structures of DLL1 and DLL3 for their biochemical properties and their functionality in the 
developing embryo.  
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3 Material and Methods 
3.1 Material 
3.1.1 Primers 
Primers were synthesized by MWG Biotech AG or Operon Biotechnologies GmbH. 
Primers used for cloning of targeting and expression constructs: 
Primer  Sequence 5’ to 3’ 
Dll3BamHIfor AGG CAG GCG GAT CCA CAG CGC 
SacIDll3HArev GAG CTC CTA TTA TCA AGC GTA GTC 
SacI3xstopDll3rev GAG CTC CTA TTA TCA GGC CTC TCG TGC ATA AAT GGA AG 
ScaITDPIDll3EGF1for AGT ACT GCA CTG ACC CAA TCT GTC GAC CAG GCT GCA GCC C 
Dll3EGF3rev ATC TTC ACC GCC AAC ACA CAA GCC 
NdeDll1-Dll3for CAT ATG GAG AGC CAG GGC GGG CCC TTC CCC TGG CTG CCT CCC GCC TTG GGG CTG CTG 
Dll3Flag3xstopNotIrev 
GCG GCC GCC TAT TAT CAT TTA TCG TCA TCG TCT 
TTG TAG TCT GCG GCC TCT CGT GCA TAA ATG GAA 
GGG 
NotIfor3'Dll1 GCG GCC GCA CAG ACC TCC 
EcoRI-Dll1kozakATG GAA TTC GTC CAG CGG TAC CAT GG 
BspEIDll3EGF2rev TCC GGA CAC CTC ACA TCG AAG CCC GTA 
BspEIDll1EGF3for TCC GGA GTC ACG TGT ACT CAC CAT AAG CCG TGC 
Dll1EGF5rev CGT CCT CCA TTG AAG CAA GGG CC 
NotIfor3'Dll1 GCG GCC GCA CAG ACC TCC 
SalIDll1EGF2rev GTC GAC AGT AGT TCA GGT CTT GGT TGC A 
Dll3ECD-
DLL1TMICDfor 
GCG GAT CCA CAG CGC TTT CTT GTG GCC GTG TGT 
GCC GGG GTG 
Flag3xSTOPNotIrev GCG GCC GCC TAT TAT CAT TTA TCG TCA TCG TCT TTG 
YY-AV-for GTT TGT GTG TGA CGA GCA CGC CGT CGG AGA AGG TTG CTC TG 
YY-AV-rev CAG AGC AAC CTT CTC CGA CGG CGT GCT CGT CAC ACA CAA AC 
GWKG-AAAA for GAA GAT GTG CGA CCC TGC CGC GGC AGC CCA GTA CTG CAC TGA CC 
GWKG-AAAA rev GGT CAG TGC AGT ACT GGG CTG CCG CGG CAG GGT CGC ACA TCT TC 
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YY-AY for GTT TGT GTG TGA CGA GCA CGC CTA CGG AGA AGG TTG CTC TGT GTT CTG C 
YY-AY rev GCA GAA CAC AGA GCA ACC TTC TCC GTA GGC GTG CTC GTC ACA CAC AAA C 
YY-FY for GTT TGT GTG TGA CGA GCA CTT CTA CGG AGA AGG TTG CTC TGT GTT CTG C 
YY-FY rev GCA GAA CAC AGA GCA ACC TTC TCC GTA GAA GTG CTC GTC ACA CAC AAA C 
YY-YF for GTT TGT GTG TGA CGA GCA CTA CTT CGG AGA AGG TTG CTC TG 
YY-YF rev CAG AGC AAC CTT CTC CGA AGT AGT GCT CGT CAC ACA CAA AC 
YY-FF for GTT TGT GTG TGA CGA GCA CTT CTT CGG AGA AGG TTG CTC TG 
YY-FF rev CAG AGC AAC CTT CTC CGA AGA AGT GCT CGT CAC ACA CAA AC 
Primers used for genotyping of mice and embryos: 
Name Sequence 5’ to 3’ 
EGF3’#1 TGT CAC GTC CTG CAC GAC G 
EGF3’#2 GGT ATC GGA TGC ACT CAT CGC 
EGF∆neo FOR ATG GAC AGC ATT TCC TCC TGC CTC 
EGF∆neo REV GCC AGT CAG TTC CCA GTA AGA AGT C 
Dll1 F2 CTC CTG CGC GGT GGA GGG AGG 
Dll1 R1 GGA GTC GAC ACC CAG CAC TGG CG 
Melta38 ATC CCT GGG TCT TTG AAG AAG 
LacZ1/Dll1 Ko CAA ATT CAG ACG GCA AAC 
Dll3 pu1 ACG AGC GTC CCG GTC TAT AC 
Dll3 pu2 AGG TGG AGG TTG GAC TCA CC 
 
 
3.1.2 Synthetic DNA, Vectors and cDNAs 
The gene fragment used for chimeric ligands J and M was synthesized by Entelechon GmbH 
(delivered doublestranded and subcloned). 
Gene fragment: 
Gene fragment Sequence 5’ to 3’ 
NDLL1-DSLDLL3-182 
CAG TAG CGG CCG CAC AGA CCT CCG GTA CTC TTA 
CCG GTT TGT GTG CGA GCC GCC CGC CGT CGG GGC 
CGC CTG CGC GCG CCT GTG CCG CTC ACG CAG TGC 
CCC CTC GCG GTG TGG CCC GGG ACT GCG ACC CTG 
CAC GCC ATT CCC AGA CGA GTG CGA AGC CCC GTC 
TGT GTG TCG ACC AGG CT 
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Vectors and cDNA: 
Vector / cDNA Origin  
pTracerCMV Clontech 
pTracerCMV-Dll1Flag (Shimizu et al., 2000b) S. Chiba, Univ. of Tokyo, Tokyo, Japan 
pGEMzf Promega 
RBP-luc (Minoguchi et al., 1997) A. Israel, Inst. Pasteur, Paris, France 
Hes1-luc (Logeat et al., 1998) A. Israel, Inst. Pasteur, Paris, France 
pSL1180 Amersham 
pBluescript II  Stratagene 
pNEB193 New England Biolabs 
pLitmus29 New England Biolabs 
Dll3 cDNA 
(Dunwoodie et al., 1997) 
S. Dunwoodie, Victor Chang Cardiac Research Institute, 
Darlinghurst, Australia 
  
3.1.3 Media 
Bacterial culture 
LB-medium: 10 g bacto-tryptone; 5 g yeast extract; 5 g NaCl ad 1000 ml 
Ampicillin was added after autoclaving if required 
(100 µg/ml ampicillin) 
 
LB-agar plates: LB-medium (see above) with additional 1.5% bacto-agar  
Additives were added shortly before pouring the plates if required 
(100 µg/ml ampicillin; 1 mM IPTG; 50 µg/ml X-Gal) 
Cell culture 
CHO-medium: DMEM/F12 1:1, 10% FCS, 2 mM Glutamax, 100 U/ml penicillin, 
100 µg/ml streptomycin 
 
HeLa-medium: 
(also OP9 and L cells) 
DMEM, 10% FCS, 2 mM Glutamax, 100 U/ml penicillin, 
100 µg/ml streptomycin 
 
HEK 293 medium: DMEM, 10% FCS, 2mM Glutamax, 1 mM sodiumpyruvate, 
100 µM non-essential amino acids, 100 µM β-mercaptoethanol, 
100 U/ml penicillin, 100 µg/ml streptomycin 
 
  
Ingredients for cell culture media were obtained from GibcoBRL. Prior to use, fetal bovine 
serum (FCS) was heat inactivated by incubation at 56°C in a water bath for 30 min to destroy 
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complement proteins. Freezing media were prepared by adding 10% DMSO and 10% FCS to 
the normal medium.  
3.1.4 Cells 
Bacteria 
The Escherichia coli variants XL1-blue (Stratagene) and TOP10 (Invitrogen) were used for 
amplification of vector DNA. 
Eukaryotes 
The type and source of cell lines used for transfection, generation of stable cell lines, 
transactivation assays, cell surface biotinylation, metabolic labeling and immunofluorescence 
stainings are listed below. All cell lines grow as an adherent monolayer in cell culture dishes. 
Cell lines: 
Cell line Origin Source 
CHO chinese hamster  
ovary Gossler Lab 
CHO-PSGL-1 chinese hamster  
ovary 
D. Vestweber, Univ. of Münster, Münster, 
Germany 
HeLa human  
cervical cancer Gossler Lab 
HeLa-N1 human 
cervical cancer A. Israel, Institute Pasteur, Paris, France 
HEK293 human 
embryonic kidney Gossler Lab 
L cell-Dll1HA mouse fibroblast G. Weinmaster, UCLA, Los Angeles, USA 
OP9 
mouse 
stromal cells 
derived from bone 
marrow 
A. Israel, Institute Pasteur, Paris, France 
OP9MIG 
mouse 
stromal cells 
derived from bone 
marrow 
A. Israel, Institute Pasteur, Paris, France 
OP9-Dll1 
mouse 
stromal cells 
derived from bone 
marrow 
A. Israel, Institute Pasteur, Paris, France 
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3.1.5 Antibodies 
Primary and secondary antibodies used for Western blot analysis (WB), immunofluorescence 
(IF) of cells, whole mount immunofluorescence (WM-IF) of presomitic mesoderm and 
immunoprecipitation (IP) are listed below. 
Primary antibodies: 
Antibody directed 
against 
Host 
species Source 
Application, 
dilution 
anti-Calreticulin  rabbit, polyclonal Abcam IF, 1:50 
anti-cleaved 
Notch1 (Val1744) 
Val1744  
of the cleaved 
Notch ICD 
rabbit, 
polyclonal 
Cell Signaling 
 
WB, 1:1000  
anti-Dll1  
(H-265) C-terminus 
rabbit, 
polyclonal Santa Cruz WM-IF, 1:100 
anti-Dll1 1F9 extracellular peptide 
rat, 
monoclonal 
E. Kremmer, GSF 
Munich, Germany 
IF, 1:10-1:50 
IP, 1:50 
anti-Dll1 2A5 intracellular peptide 
rat, 
monoclonal 
E. Kremmer, GSF 
Munich, Germany IF, 1:10-1:50 
anti-Dll1 2B3 extracellular  peptide  
rat, 
monoclonal 
E. Kremmer, GSF 
Munich, Germany IF, 1:10-1:50 
anti-Dll3 C2 C-terminus (intracellular) 
guinea pig, 
polyclonal 
S. Dunwoodie,    
Victor Chang Cardiac 
Research Institute, 
Darlinghurst, Australia 
IF, 1:50 
WM-IF, 1:50 
anti-Dll3 N2 N-terminus (extracellular) 
guinea-pig, 
polyclonal 
S. Dunwoodie,    
Victor Chang Cardiac 
Research Institute, 
Darlinghurst, Australia 
IF, 1:50 
WM-IF, 1:50 
anti-Dll3-ICD 
(1D1) 
intracellular 
domain  
rat, 
monoclonal 
E. Kremmer, GSF 
Munich, Germany IF, 1:10 
anti-Flag (M2) peptide DYKDDDDK 
mouse, 
monoclonal Sigma 
WB, 1:10000 
IF, 1:5000 
anti-GM130 (35) C-terminus mouse, 
monoclonal BD Biosciences 
IF, 1:250 
WM-IF, 1:250 
anti-HA (3F10) peptide YPYDVPDYA 
rat, 
monoclonal Roche IF, 1:100 
anti-pan Cadherin 
(CH-19) C-terminus 
mouse, 
monoclonal Sigma WM-IF, 1:250 
anti-PSGL-1 
(4RA10)  
rat, 
monoclonal 
D. Vestweber, Univ. 
of Münster, Germany 
WB,1:100 
IP, 1:100 
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Secondary antibodies 
antibody host 
species Source application, dilution 
anti-guinea pig Texas Red donkey Jackson ImmunoResearch Laboratories, Inc. 
IF, 1:200 
WM-IF, 1:200 
anti-mouse Alexa Fluor®488 donkey Invitrogen IF, 1:500 WM-IF, 1:500 
anti-mouse FITC donkey Jackson ImmunoResearch Laboratories, Inc. IF, 1:1000 
anti-mouse POD sheep Amersham WB, 1:10000 
anti-mouse Texas Red donkey Jackson ImmunoResearch Laboratories, Inc. 
IF: 1:2000 
WM-IF, 1:200 
anti-rabbit Alexa Fluor®488 donkey Invitrogen WM-IF, 1:500 
anti-rabbit FITC donkey Jackson ImmunoResearch Laboratories, Inc. IF, 1:1000 
anti-rat Alexa Fluor®488 donkey Invitrogen IF, 1:500 WM-IF, 1:500 
anti-rat FITC donkey Jackson ImmunoResearch Laboratories, Inc. IF, 1:1000 
anti-rat POD goat Amersham WB, 1:10000 
anti-rat Texas Red donkey Jackson ImmunoResearch Laboratories, Inc. 
IF, 1:2000 
WM-IF, 1:200 
    
3.1.6 Data bases 
In the course of this project the following data bases were used: 
 
Ensembl genome browser (http://www.ensembl.org) 
Expert Protein Analysis System (ExPASy) (http://www.expasy.org) 
Mouse Genome Imformatics (MGI) (http://www.informatics.jax.org) 
National Center for Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov) 
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3.1.7 Computer programs  
The following computer programs were used in the course of this project: 
 
Text processing: Word 2003 (Microsoft); Reader 6.0 (Adobe) 
 
Image acquisition: Fujifilm Photograb-300Z (Fuji Photo Film Co.); 
 LSM 510 Confocal Software (Carl Zeiss MicroImaging, Inc) 
 Fujifilm Image reader Version 1.8E (Fuji Photo Film Co) 
 FotoLookSA3.03 (Agfa-Gevaert AG) 
 BAS-100 MacBASV2.2 (Fuji Photo Film Co.) 
 
Image processing: Photoshop 7.0 und CS (Adobe), Illustrator CS (Adobe) 
 
Sequence processing: MacVectorTM 7.2 (Accelrys Inc.) 
 
Online search: Netscape Communicator 7.1 (Netscape Communications Corp.) 
 Safari Version 2.0.4 (Apple Computer, Inc.) 
 
Literature management: Reference manager 11 (Thomson ResearchSoft) 
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3.2 Methods of molecular biology 
3.2.1 Standard conditions and methods of molecular biology 
Common methods of molecular biology such as precipitation of nucleic acids, restriction 
digests of plasmid DNA, ligation of DNA fragments, transformation of electrocompetent 
E. coli cells, analytic preparation of plasmid DNA by alkaline lysis, photometric 
quantification of nucleic acids and agarose gel electrophoresis to separate DNA fragments 
were essentially performed as described by Sambrook et al. (1989) and Ausubel et al. (1998). 
Restriction digests were performed with enzymes from New England Biolabs, MBI 
Fermentas, Stratagene and Roche with the supplied buffers as recommended by the 
manufacturer. Agarose gel electrophoresis was performed using TAE buffer, gel elution of 
DNA fragments was performed using the “NucleoSpin® Extract II” Kit (Macherey-Nagel). 
For preparation of “clean” plasmid DNA the “GenEluteTM Plasmid Miniprep Kit“ (Sigma) 
was used according to the manufacturer’s protocol. For subcloning of PCR products the 
“pGEM®-T Easy Vector System“ (Promega) was used. DNA sequencing was performed by 
Agowa GmbH or in house using the “BigDyeTM Terminator Cycle Sequencing Ready 
Reaction kit” (PE Applied Biosystems). 
3.2.2 Generation of expression constructs 
For cloning of eukaryotic expression vectors the pTracerCMV plasmid was used carrying an 
ampicillin-resistance cassette for selection in bacteria, a zeocin-resistance cassette for 
selection in cell culture and a CMV-promotor upstream of the multiple cloning site. The 
pTracer-Dll1Flag plasmid was modified by inserting an IRES-neo cassette after the Dll1Flag 
ORF and served as a shuttle vector (pTracer-Dll1flagIRESneo) for expression of flag-tagged 
Dll1, Dll3 as well as mutant and chimeric ligands. In addition, HA-tagged versions of Dll1 
and Dll3 were cloned into pTracer. The Dll3HA construct was partially cloned by Claudia 
Brockmeyer and the Dll3flag and Dll1HA contructs were cloned by Stephan Hegge under my 
supervision during their diploma thesis. The integrity of all constructs was verified by 
sequencing. 
Chimeric ligands 
Chimeric ligands were generated by conventional cloning methods. Junctions between the 
Dll1 and Dll3 sequences were created by PCR mutagenesis using primers with an overhang 
containing restriction sites without changing the amino acid sequence. In the case of chimeric 
ligands D and E, two gene fragments containing a deletion or an insertion between EGF1 and 
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2 were synthesized (GenScript). For cloning of the constructs J and M a gene fragment 
containing the N-terminus of DLL1 and the link to the DLL3 DSL domain was synthesized 
by Entelechon GmbH. The junctions of Dll1 and Dll3 sequences in chimeric ligands are 
shown in the table below.  
Construct A (internal designation swap1/3):  
By PCR the EGF-like repeats 1 to 3 of the Dll3 ORF were amplified using a forward primer 
(ScaITDPIDll3EGF1for) derived from the start of EGF1 additionally containing a ScaI site 
and a Dll1 sequence linker in the overhang and the reverse primer Dll3EGF3rev. The 
subcloned PCR product was digested with ScaI and XmaI and the resulting 262 bp fragment 
was isolated. Together with the ~690 bp EcoRI/ScaI Dll1 fragment from pTracer-Dll1Flag it 
was subcloned into the pBSII vector. The resulting vector was digested with EcoRI/ XmaI and 
the ~950 bp chimeric fragment was then cloned into the pTracer-Dll3flagIRESneo together 
with the ~540 bp XmaI/SacII fragment of the Dll3 ORF.  
Construct B (internal designation Dll1-Dll3):  
By PCR the transmembrane and intracellular domain (TM-ICD) of the Dll3 ORF including 
the flag tag and stop codons was amplified using a forward primer (NdeDll1-Dll3for) derived 
from the start of the DLL3 transmembrane domain additionally containing a Dll1 sequence 
linker with a NdeI site in the overhang and the reverse primer Dll3Flag3xstopNotIrev. The 
subcloned PCR product was digested with NdeI and NotI and the ~350 bp fragment was 
isolated. Together with the ~1.6 kb EcoRI/NdeI Dll1 fragment from pTracer-Dll1flagIRESneo 
it was subcloned into the pTracer-Dll1flagIRESneo vector. 
Construct D (internal designation swap Bsp):  
By PCR the N-terminus, DSL domain and EGF1 and 2 up to the start of EGF3 of chimeric 
ligand A were amplified using the forward primer EcoRI-Dll1kozakATG and a reverse primer 
(BspEIDll3EGF2rev) derived from the end of EGF2 and the following spacer sequence 
additionally containing a Dll1 sequence linker with a BspEI site in the overhang.  By a second 
PCR EGF2 to 4 of Dll1 were amplified using a forward primer (BspEIDll1EGF3for) derived 
from the start of EGF2 including a BspEI site in the overhang and a reverse primer 
(Dll1EGF5rev) derived from the spacer sequence between EGF4 and 5 containing a BlpI site. 
The subcloned product of PCR1 was digested with AgeI and BspEI and the ~430 bp fragment 
was isolated. Together with the ~200 bp BspEI/BlpI fragment from PCR2 it was subcloned 
into the pTracer-Dll1flagIRESneo vector. The BspEI site was generated by conservative 
mutations of the Dll1 sequence without altering the amino acid sequence. 
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Construct G (internal designation swap Sal131):  
Together with the ~1.7 kb EcoRI/BamHI fragment from construct L the ~600 bp BamHI/NotI 
fragment from construct K was cloned into the pTracer-Dll1flagIRESneo vector. 
Construct I (internal designation swap 131):  
Together with the ~1.5 kb EcoRI/BamHI fragment from construct A the ~600 bp BamHI/NotI 
fragment from construct K was cloned into the pTracer-Dll1flagIRESneo vector. 
Construct J (internal designation N131):  
The gene fragment NDLL1-DSLDLL3-182 containing a short sequence of the N-terminus of 
Dll1 ORF and the transition to the Dll3 DSL domain was digested with NotI and SalI. The 
~160 bp fragment was isolated and cloned together with the ~1.4 kb SalI/NotI fragment from 
construct K into the pTracer-Dll1flagIRESneo vector. 
Construct K (internal designation Dll3-Dll1):  
By PCR the transmembrane and intracellular domain (TM-ICD) of Dll1 ORF including the 
flag tag, stop codons and a NotI site were amplified using a forward primer (Dll3ECD-
DLL1TMICDfor) derived from the start the Dll1 transmembrane domain additionally 
containing a Dll3 sequence linker with a BamHI site in the overhang and the reverse primer 
Flag3xSTOPNotIrev. The subcloned PCR product was digested with BamHI and NotI and the 
~650 bp fragment was isolated. Together with the ~1.5 kb EcoRI/BamHI Dll3 fragment from 
pTracer-Dll3flagIRESneo it was subcloned into the pTracer-Dll1flagIRESneo vector. 
Construct L (internal designation swap Sal):  
By PCR the DSL domain and EGF-like repeats 1 and 2 of the Dll1 ORF were amplified using 
a forward primer (NotIfor3'Dll1) derived from the Dll1 sequence upstream of the DSL 
domain containing a NotI site and a reverse primer (SalIDll1EGF2rev) derived from the end 
of EGF2 and the following spacer sequence additionally containing a Dll3 sequence linker 
with a SalI site in the overhang. The subcloned PCR product was digested with NotI and SalI 
and the ~350 bp fragment was isolated. Together with the ~1.1 kb SalI/NotI Dll3Flag 
fragment from pTracer-Dll3flagIRESneo it was cloned into the pTracer-Dll1flagIRESneo 
vector. 
Construct M (internal designation N13):  
The gene fragment NDLL1-DSLDLL3-182 containing a short sequence of the N-terminus of 
Dll1 ORF and the transition to the Dll3 DSL domain was digested with NotI and SalI. The 
~160 bp fragment was isolated and cloned together with the ~1.1 kb SalI/NotI fragment from 
pTracer-Dll3flagIRESneo into the pTracer-Dll1flagIRESneo vector. 
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Junctions of Dll1 and Dll3 sequences in the chimeric ligands: 
Construct Sequence junction 
A ...TGC ACT GAC CCA ATC tgt cga cca ggc tgc... 
    C   T   D   P   I   c   r   p   g   c  
B ...GGG CCC TTC CCC TGG ctg cct ccc gcc ttg... 
    G   P   F   P   W   l   p   p   a   l  
C 
...AGC GCC ATG ACC tgc gca gat gga ccc... 
    S   A   M   T   c   a   d   g   p  
...cca cag cgc ttt ctt GTG GCC GTG TGT... 
    p   q   r   f   l   V   A   V   C  
D 
...ACT GAC CCA ATC tgt cga cca ggc tgc... 
    T   D   P   I   c   r   p   g   c 
...gtg tcc gga gtc acg TGT ACT CAC CAT... 
    v   s   g   v   t   C   T   H   H  
E 
...GGC CGC TAC TGC acg gtc cct gtc tcc acc agt agc  
    G   R   Y   C   t   v   p   v   s   t   s   s    
   tgc ctg aac tcc agg gtt cct ggt cct gcc agc act  
    c   l   n   s   r   v   p   g   p   a   s   t      
   gga tgc ctt tta cct ggg cct gga cct TGC ATC CGA  
    g   c   l   l   p   g   p   g   p   C   I   R    
   TAC CCA...  
    Y   P 
F 
...ACT GAC CCA ATC tgt cga cca ggc tgc... 
    T   D   P   I   c   r   p   g   c 
...act gga ccc ctc tgc GAT GAG tgt gat ggg aac cca...  
    t   g   p   l   c   D   E   c   d   g   n   p 
...gtg tcc gga gtc acg TGT ACT CAC CAT AAG... 
    v   s   g   v   t   C   T   H   H   K  
G 
...GAC CTG AAC TAC tgt cga cca ggc tgc...  
    D   L   N   Y   c   r   p   g   c 
...cca cag cgc ttt ctt GTG GCC GTG TGT... 
    p   q   r   f   l   V   A   V   C  
I 
...TGC ACT GAC CCA ATC tgt cga cca ggc tgc...  
    C   T   D   P   I   c   r   p   g   c 
...cca cag cgc ttt ctt GTG GCC GTG TGT... 
    p   q   r   f   l   V   A   V   C  
J 
...TCT TAC CGG TTT GTG tgc gag ccg ccc gcc...  
    S   Y   R   F   V   c   e   p   p   a 
...cca cag cgc ttt ctt GTG GCC GTG TGT... 
    p   q   r   f   l   V   A   V   C  
K ...cca cag cgc ttt ctt GTG GCC GTG TGT GCC... 
    p   q   r   f   l   V   A   V   C   A 
L ...GAC CTG AAC TAC tgt cga cca ggc tgc... 
    D   L   N   Y   c   r   p   g   c 
M ...TCT TAC CGG TTT GTG tgc gag ccg ccc gcc...  
    S   Y   R   F   V   c   e   p   p   a  
 
 Constructs C, E and F were cloned by Dr. Katrin Serth and Patricia Delany-Heiken. Construct H was cloned by 
Claudia Brockmeyer under my supervision during her diploma thesis. 
Dll1 sequences: UPPER case (NUCLEOTIDES)/BOLD (AMINO ACIDS)  
Dll3 sequences: lower case (nucleotides)/italics (amino acids) 
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Dll1 DSL mutant ligands: 
Plasmids for eukaryotic expression of the DLL1 DSL mutant proteins were generated by 
mutating the subcloned NotI/NdeI fragment of Dll1 (Ago#951) using the “QuikChange Site-
directed Mutagenesis Kit” (Stratagene) with the following primers.  
The mutated NotI/NdeI fragment of Dll1 was cloned into the pTracer-Dll1FlagIRESneo 
vector. The DLL1 DSL-AY and the DLL1 DSL-FY constructs were cloned by Claudia 
Brockmeyer under my supervision during her diploma thesis. 
3.2.3 Generation of the targeting constructs 
The strategy of the targeting constructs was adopted from a strategy developed by Dr. Ralf 
Cordes. For the generation of the Dll1Dll3ki and Dll1Dll1DSLmut constructs, homologous regions 
of the Dll1 locus and transitions of different components were cloned from the Dll1Dll1ki 
construct (Ago#474). The Dll3 ORF (with or without a C-terminal HA tag) was fused to a 
genomic Dll1 SacI/EcoRI fragment containing part of exons 9, 10, and 11. A PGK neomycin 
expression cassette flanked by loxP sites was introduced 3′ to the Dll3-Dll1 fusion. A 4.6 kb 
BamHI/KpnI fragment of Dll1 genomic DNA upstream of the ATG fused in frame to Dll3, 
and ~3 kb of Dll1 genomic DNA downstream of the SalI site in exon 2 were included as 
regions of 5′ and 3′ homology, respectively. A diphtheria toxin A expression cassette was 
cloned both upstream and downstream of the homology arms.  
3.2.4 Generation of knock-in mice targeting the Dll1 locus 
Linearized vector DNA was electroporated into 129Sv/ImJ embryonic stem cells and selected 
as described previously (Abdelkhalek et al., 2004). Correctly targeted clones were identified 
by PCR using primers derived from the neo sequence and from genomic sequences 
downstream of the targeting vector. PCR-positive ES cell clones were verified by Southern 
blot analysis using external probes located 3′ and 5′ to the regions of homology in the vector. 
PCR-positive ES cell clones were used for blastocyst injection. Blastocysts were transferred 
into pseudo-pregnant females to generate chimeric mice. After germline transmission was 
Construct Mutation Forward primer Reverse primer 
DLL1 DSL-∆Y YYAV YY-AV-for YY-AV-rev 
DLL1 DSL-∆G GWKGAAAA GWKG-AAAA for GWKG-AAAA rev 
DLL1 DSL-AY YYAY YY-AY for YY-AY rev 
DLL1 DSL-FY YYFY YY-FY for YY-FY rev 
DLL1 DSL-FF YYFF YY-FF for YY-FF rev 
DLL1 DSL-YF YYYF YY-YF for YY-YF rev 
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obtained the knock-in mice were passed through the germline of ZP3::Cre females (de Vries 
et al., 2000) to remove the floxed neo cassette that was included in the targeting vectors.  
Electroporation of the ES cells with the targeting constructs, ES cell culture as well as 
blastocyst injection of verified ES cell clones, blastocyst transfer in pseudo-pregnant females 
and subsequent crossing of chimeric mice were kindly performed by Dr. Karin Schuster-
Gossler with technical assistance by Hannelore Burkhardt in the cell culture and Anatoli 
Heiser in the mouse work. 
3.2.5 Southern blot analysis 
PCR-positive ES cell clones and offspring of chimeric founder mice were tested for the 
correct homologous recombination event by Southern Blot Analysis (Chomczynski and 
Qasba, 1984; Southern, 1975). 
Alkaline transfer 
Denaturation buffer: 0.5 M NaOH, 1.5 M NaCl 
Neutralization buffer: 50 mM NaPi (prepared from 1 M NaPi stock pH 6.7) 
  
Genomic DNA was digested with BamHI (Roche) overnight at 37°C. DNA fragments were 
separated by agarose gel electrophoresis, stained with ethidiumbromide and documented with 
a size standard. To improve the transfer of large DNA fragments to the membrane, the DNA 
was depurinated by incubating the agarose gel in 0.15 M HCl for 15 min. Afterwards the 
agarose gels were rinsed in deionized water and soaked with denaturation buffer twice for 20 
min with gentle rocking. To immobilize the DNA on a membrane the DNA fragments were 
transferred from the agarose gel onto a nylon membrane (Hybond-N, Amersham) by 
traditional semi-dry capillary blotting overnight. The gel/membrane sandwich was set up as 
follows (from bottom to top): two layers of Whatman 3MM-filter paper soaked with 
denaturing buffer, agarose gel, membrane, two layers of Whatman 3MM-filter paper soaked 
with denaturing buffer. A stack of dry tissue paper on top provided the soaking force. After 
the transfer the nylon membranes were neutralized in 50 mM NaPi buffer for 20 min and 
crosslinked with 1200 J in a UV-Crosslinker (Stratagene). 
Synthesis of radioactive labeled DNA probes 
Radioactive labeled DNA probes were generated according to the method described by 
(Feinberg and Vogelstein, 1983). Using random primers, [α−32P]-dCTP was incorporated into 
the newly synthesized DNA strand by the Klenow fragment of DNA polymerase I. 
For the 3’probe 5 µg of the EGF3’probe plasmid (Ago#1667) were digested with EcoRI and 
the 500 bp fragment was isolated and used for labeling. For the 5’ probe 5 µg of the 
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EGF5’probe plasmid (Ago#1668) were digested with BamHI and AvaII. The 320 bp fragment 
was separated from the 200 bp fragment on a 1.5% agarose gel, isolated and used for labeling. 
For the synthesis of radioactive labeled DNA probes the „Prime-It®II Random Primer 
Labeling Kit” (Stratagene) was used. 
25 ng of the DNA fragment was denatured together with 10 µl random hexamer primer 
solution filled with ddH2O up to a total volume of 33 µl at 96°C for 5 min. 10 µl labelling 
buffer, 5 µl [α−32P]-dCTP (10 µCi/µl; 3000 Ci/mmol) and 1 µl exo-Klenow emzyme 
(5 units/µl) were added and the reaction mix was incubated for at least one hour (or overnight) 
at 37°C. Free nucleotides were removed by precipitation of the labeled DNA fragments. The 
DNA pellet was resolved in 100 µl ddH20. 1 µl was measured in a scintillation-counter (LS 
6000SE; Beckman). 
Hybridization of the Southern blot 
Wash buffer:   1% SDS, 40 mM NaPi pH 6.7 
Church buffer: 7% SDS, 300 mM NaPi pH 6.7, 5 mM EDTA 
  
The membrane filters with immobilized DNA fragments were placed in hybridization glass 
tubes and shortly incubated with prewarmed wash buffer at 65°C. Subsequently, the filters 
were saturated by three hour incubation with 20 ml prewarmed prehybridization buffer 
(Church) at 65°C with continuous rotation in the hybridization oven. 2 x 106 cpm/ml 
radioactive labelled DNA probe were added to the hybridization solution (Church) and boiled 
for 10 min. The prehybridization buffer was discarded and replaced with the hybridization 
solution. The membranes were incubated overnight at 65°C under continuous rotation in an 
hybridization oven. After washing three times for 20 min with wash buffer at 65°C the 
membranes were wrapped with transparent foil and exposed to X-ray films (HyperfilmTM MP 
Amersham) with intensifying screen for several days at -80°C or to a phosphor imaging plate 
at room temperature to detect bound probe. 
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3.2.6 Genotyping of mice and embryos 
DNA isolation from tail biopsies and yolk sacs 
TE buffer:  10 mM Tris-Cl, pH 8.0, 1 mM EDTA 
Proteinase K buffer:  0.1 M Tris/HCl pH 8.0, 5 mM EDTA, 0.5% SDS,  
200 µg/ml proteinase K  
  
To isolate DNA from tail biopsies the tail clippings of 2 to 5 mm length were incubated 
overnight in 500 µl proteinase K buffer at 56°C. The samples were centrifuged for 10 min at 
16000 g to remove unsoluble debris. Genomic DNA in the supernatant was precipitated by 
addition of 450 µl isopropanol. After washing with 70% ethanol 100-200 µl TE buffer were 
added to the DNA pellet. Incubation of the DNA for 30 min at 65°C inactivated DNases and 
completely dissolved the DNA. Genomic DNA solution was stored at 4°C. 
Genotyping by PCR 
10x PCR reaction buffer:  500 mM KCl, 100 mM Tris/HCl pH 8.8, 0.1% Triton 
  
To genotype mice or embryos, genomic DNA was extracted from tail clippings, yolk sacs or 
embryonic tissues and genotyped by PCR. All reactions were performed in thin-walled PCR 
tubes and were run in PCR cyclers Primus 96plus (MWG Biotech AG). 
EGF∆ neo- PCR 
PCR program:  PCR reaction set up: 
1x 94°C 5 min 32.5 µl ddH2O 
 94°C 30 sec 5 µl 10 x PCR reaction buffer 
30x 57°C 1 min 5 µl 15 mM MgCl2 
 72°C 30 sec 2.5 µl DMSO 
  
 1 µl EGF∆neo FOR (see 3.1.1) 
  
 1 µl EGF∆neo REV (see 3.1.1) 
  
 1 µl dNTPs (10 mM) 
  
 1 µl Taq polymerase 
  
 1 µl genomic DNA 
     
To detect the Dll1Dll3HA, Dll1Dll3, Dll1Dll1DSL-∆Y or Dll1Dll1DSL-∆G alleles after Cre recombinase-
mediated excision of the floxed PGKneo cassette a forward primer aligning to the 3’UTR of 
the 11th exon of Dll1 and a reverse primer aligning to the 2nd intron were used to amplify a 
280 bp PCR product. 
  Material and Methods 
  37 
Dll1LacZ-PCR 
PCR program:  
1x 94°C 5 min   
 94°C 30 sec   
40x 53°C 30 min   
 72°C 30 sec   
     
To detect the Dll1 null allele Dll1LacZ the PCR reaction mix described for the EGF∆ neo- PCR 
 was set up with the primers Melta38 and LacZ1/Dll1 Ko (see 3.1.1). After amplification with 
the program above a 580 bp PCR product indicated the Dll1LacZ allele. 
Dll1 wt-PCR 
PCR program:  
1x 94°C 3 min   
 94°C 30 sec   
40x 63°C 30 min   
 72°C 45 sec   
     
To detect the Dll1 wildtype allele the PCR reaction mix described for the EGF∆ neo- PCR 
was set up with the primers Dll1F2 and Dll1R1 (see 3.1.1). After amplification with the 
following program a 425 bp PCR product indicated the Dll1 wildtype allele. 
Dll3 pudgy-PCR  
PCR program:  PCR reaction set up: 
1x 94°C 3 min 65 µl ddH2O 
 94°C 30 sec 10 µl 10 x PCR reaction buffer 
40x 61°C 30 min 10 µl 15 mM MgCl2 
 72°C 45 sec 5 µl DMSO 
  
 2 µl primer Dll3 pu1 (see 3.1.1) 
  
 2 µl primer Dll3 pu2 (see 3.1.1) 
  
 2 µl dNTPs (10 mM) 
  
 2 µl Taq polymerase 
  
 2 µl Genomic DNA 
     
To detect the Dll3 null allele (pudgy) the PCR reaction was set up and run as described above. 
After amplification, PCR products were precipitated, cleaved with HaeIII and separated on 
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3% agarose gels. A 100 bp fragment indicated the Dll3pu allele, a 65 bp fragment the Dll3 
wildtype allele. 
3.2.7 PCR-screening of ES cell clones for correct targeting events 
Mastermix 1:  Mastermix 2: 
1 µl  primer EGF3’#1 (see 3.1.1) 5 µl 10x PCR buffer (Roche) 
1 µl  primer EGF3’#2 (see 3.1.1) 19 µl ddH2O 
1 µl  dNTPs 0.4 µl High Fidelity Taq polymerase 
20 µl  ddH2O 1 µl Taq polymerase (conc.) 
    
PCR program:  
1x 94°C 2min   
 94°C 30 sec   
10x 58°C 30 sec   
 68°C 4 min   
 94°C 30 sec   
20x 58°C 30 sec   
 68°C 4 min + 5 sec each cycle   
 68°C 7 min   
     
To genotype the G418-resistant ES cells and the offspring of the founder mice the “Expand 
High Fidelity PCR System” (Roche) was used. Two mastermixes were prepared. After filling 
23 µl of Mastermix 1 in each tube, 2 µl ES cell DNA and 25 µl of Mastermix 2 were added 
PCR reactions were run on a 0.7% agarose gel. For correctly targeted alleles a 4.2 kb PCR 
product was expected. 
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3.3 Methods of protein biochemistry 
3.3.1 SDS-PAGE 
Stacking gel buffer: 0.5 M Tris/HCl pH 6.8, 0.4% SDS 
Separating gel buffer: 1.5 M Tris/HCl pH 8.8, 0.4% SDS 
2x sample buffer: 125 mM Tris/HCl pH 6.8, 20% glycerine, 4% SDS,  
2% β-mercaptoethanol, ~10 µg/ml bromphenolblue 
Electrode buffer: 25 mM Tris, 192 mM glycine, pH 8.3, 0.1% SDS 
  
10% SDS-polyacrylamide gels were prepared using 30% acrylamide/0.8% bisacrylamide, 
stacking gel buffer, seperating gel buffer, SDS, ammoniumpersulfate and TEMED according 
to standard protocols (Ausubel et al., 2007). 
Samples were boiled in sample buffer for 5 min, spun down and loaded on the gel together 
with PageRulerTM prestained protein ladder Plus (Fermentas). Gels were run in a 
electrophoresis chamber of the “Mini Protean II System” (Bio-Rad) at 200 V for ~45 min in 
electrode buffer. At this point the gels were either transferred to a membrane (see below) or 
stained with Coomassie. 
3.3.2 Western blot 
The SDS-polyacrylamide gel was transferred to a PVDF membrane by wet tank blotting using 
the “Mini Trans-Blot Electrophoretic Transfer Cell” (Bio-Rad). For this purpose the gel was 
equilibrated and the membrane, filter paper and fiber pads were soaked in transfer buffer for 
5-10 min. A transfer sandwich was prepared according to the instruction manual. A high 
intensity field transfer was performed at 100 V and limited to 350 mA for 1 h using the Bio-
Ice cooling unit. After the transfer, the membrane was blocked with 5% milk in PBST for at 
least 30 min at RT. Subsequently, the membrane was incubated with the primary antibody 
diluted in 5% milk in PBST o/n at 4°C. The next day it was washed three times with PBST for 
20 min and incubated with the secondary antibody coupled to peroxidase and diluted in 5% 
milk in PBST for 1-2 h at RT. Afterwards the membrane was washed again three times with 
PBST for 20 min and once with PBS. For POD detection the ECL Western blotting detection 
Transfer buffer: 25 mM Tris, 192 mM glycine, pH 8.3  
(w/o adjusting the pH) 
PBS: 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4,  
1.4 mM KH2PO4, pH 7.3 
PBST: PBS, 0.5% Tween20 
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reagents (Amersham) were used and the membrane was exposed to a HyperfilmTM ECL film 
(Amersham) for the required time. 
3.3.3 Cell surface biotinylation 
For the biotin-streptavidin pull down cells were plated on 60 mm ∅ cell culture dishes and 
grown to confluence. Plates were washed three times with cold PBS c/m and placed on ice 
with 500 µl PBS. 10 µl of Sulfo-NHS-LC-Biotin solution (5 mg/ml in 0.1 M sodium 
phosphate buffer, pH 7; Pierce Chemical Co.) were added three times in 10-min intervals. 
After 30 min, the biotin solution was aspirated, and the plates were washed once with 50 mM 
glycine in DMEM and incubated for 30 min to quench the biotinylation reaction. Cells were 
washed twice with PBS c/m and lysed with 400 µl RIPA. Lysates were incubated for 30 min 
on ice and centrifuged for 10 min at 12000 g to remove cellular debris. The biotinylated 
proteins were precipitated with streptavidin agarose (Sigma) overnight at 4°C. The 
streptavidin agarose beads were washed three times with RIPA before resuspension in 2× 
sample buffer. Equivalent amounts of lysates and precipitates were subjected to SDS-PAGE 
and analyzed by Western blotting as described. 
3.3.4 Metabolic labeling with [35S]-sodiumsulfate and subsequent 
immunoprecipitation 
CHO cells were grown to 80% confluence on 100 mm ∅ cell culture dishes. Cells were 
washed once with sulfate-free Joklik MEM and incubated with this medium for 24 h to empty 
PBS c/m 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4,  
1.4 mM KH2PO4, pH 7.3, 1 mM MgCl2, 0.1 mM CaCl2 
Quench buffer: 50 mM glycine in DMEM 
RIPA: 50 mM Tris/HCl, pH 8.0, 150 mM NaCl, 1% NP-40,  
0.5% DOC, 0.1% SDS, supplemented with 2.8 µg/ml aprotinin, 
0.15 mM benzamidine, 2.5 µg/ml leupeptin and 2.5 µg/ml 
pepstatin A 
  
PBS: 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4,  
1.4 mM KH2PO4, pH 7.3  
Sulfate-free Joklik MEM: MEM Joklik (Sigma) supplemented with 1.8 mM CaCl2,  
100 µM non-essential amino acids, 10% dialyzed FCS 
Lysis buffer:   PBS, 1%NP40, 1% TritonX-100, 2 µg/ml leupeptin,  
1 mM PMSF 
Coomassie Brilliant Blue: methanol, 0.1% aqueous coomassie brilliant blue, glacial acetic 
acid, (2:2:1)  
Destaining solution: 5% methanol, 7.5% glacial acetic acid 
2x sample buffer: 125 mM Tris/HCl pH 6.8, 20% glycerine, 4% SDS,  
2% β-mercaptoethanol, ~10 µg/ml bromphenolblue 
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the endogenous sulfate storage. Afterwards the medium was exchanged for sulfate-free Joklik 
MEM medium with 100 µCi/ml (3.7 MBq/ml) [35S]-Na2SO4 (PerkinElmer LAS GmbH). Cells 
were labeled for 24h at 37°C and 5% CO2. 
The next day the medium was discarded and cells were washed twice with PBS. Cells were 
lysed by addition of 700 µl lysis buffer and incubation on ice for 10 min. Cells were scraped 
off the dishes. Cell lysates were collected in separate tubes. After 30 min incubation on ice, 
lysates were centrifuged to remove unsoluble cell debris. Cleared lysates were incubated with 
antibodies against DLL1 or PSGL-1, respectively. After 2 h incubation at 4°C by continuous 
rotation on a wheel, ProteinG sepharose (GE Healthcare) was added and lysates were further 
incubated overnight.  
Sepharose beads were washed three times with lysis buffer and precipitated by centrifugation 
for 30 sec at 1000 g. Beads were boiled in 2x protein sample buffer and spun down prior to 
loading on a SDS polyacrylamide gel. After gel electrophoresis, gels were fixed by staining 
with Coomassie-brilliant Blue and subsequently destained with destaining solution. 
Afterwards gels were incubated with NAMP100 AmplifyTM fluorographic reagent 
(Amersham), vacuum-dried and wrapped in transparent film. HyperfilmTM MP (Amersham) 
films were exposed to the gels for 2-3 weeks and subsequently developed. CHO cells were 
used as a negative control. Stable CHO cells expressing PSGL-1 were used as a positive 
control for monitoring sulfation efficiency. 
3.3.5 Immunofluorescence staining 
For immunocytochemistry cells were grown on gelatine-coated coverslips. Cells were rinsed 
twice with PBS and fixed with methanol for 10 min at 4°C. After three washes with PBS, the 
cells were blocked with 5% donkey serum in PBS for 30 min at room temperature. Cells were 
incubated with the primary antibody for 1-2 h at room temperature and, after three washes 
with PBS, with the fluorochrome-conjugated secondary antibody for 1 h. After washing, the 
coverslips were mounted in Gel/Mount (Biomeda) or ProLong Gold antifade (Invitrogen). 
Texas Red-, FITC- and/or Alexa Fluor®488-labeled cells were analyzed at room temperature 
by confocal laserscanning microscopy using the LSM 510 Meta (Carl Zeiss MicroImaging, 
Inc.) connected to the inverted microscope Axiovert 200M with a Plan Apochromat 63×/1.4 
oil differential interference contrast objective. For image acquisition the LSM 510 software 
(Carl Zeiss MicroImaging, Inc.) was used. Pictures were processed and assembled using 
Photoshop and Illustrator CS. 
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3.4 Methods of cell biology 
3.4.1 Cell culture 
Cell lines were grown at 37°C and 5% CO2 in cell culture dishes.  
Cells were passaged with standard trypsinization. To store cells for a longer period, cells were 
frozen as cell suspension with freezing medium in a cryovial. For short-term storage cells 
could also be frozen as adherent monolayer in 24-well plates with added freezing medium. 
Rapid thawing of the cell cryostocks was achieved with prewarmed cell culture medium.  
3.4.2 Transfection of cells 
One day before transfection cells were seeded in cell culture dishes such that 50-70% 
confluence was achieved the next day. On the day of transfection medium was changed at 
least two hours before transfection. Cells were transfected using JetPEI transfection reagent 
(Biomol) according to the manufacturer’s protocol.  
3.4.3 Generation and subcloning of stable cell lines 
For the generation of CHO cell lines stably overexpressing a specific protein, cells were 
transfected with the corresponding construct using the JetPEI transfection reagent (Biomol), 
splitted 24 h later 1:50-1:100 on several cell culture dishes and grown under selection 
(500 µg/ml G418; 250 µg/ml zeocin) for 7-12 days. CHO cell clones were picked and 
expanded on a 96-well plate under selection. Clones were further expanded on a 24-well plate 
and duplicated. Confluent cells from one plate were lysed with 2x sample buffer, sonified and 
protein expression levels were determined by Western blot analysis. Freezing medium was 
added to the cells on the other 24-well plate and the plate was frozen at -80°C. CHO cell 
clones with efficient protein expression were thawn and expanded. Clones that showed a 
heterogenous cell staining were subcloned by a limited dilution. CHO cells were seeded on 
96-well plates in a dilution of 0.5 cells per well to get monoclonal cell populations. Cells from 
wells with single cell clones were expanded and analyzed as described above. 
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3.4.4 Notch transactivation assay 
HeLa cells stably expressing Notch1 (HeLa-N1) were transiently transfected with a luciferase 
reporter construct (RBP-luc; (Minoguchi et al., 1997) or Hes1-luc; (Logeat et al., 1998)) 
using JetPEI (Biomol), following the manufacturer’s instructions. After ~16 h, 106 transfected 
HeLa-N1 cells were cocultivated on 6-well plates for 24 h with 106 CHO cells expressing 
different ligands. Each CHO cell line was cocultivated twice per experiment. Luciferase 
activity was measured using the “Dual-Luciferase Reporter Assay System” (Promega) 
following the manufacturer’s instructions or as decribed below.  
After cocultivation cells were washed once with PBS and lyzed by adding 200 µl extraction 
buffer. After 10 min, cells were scraped off the dishes and incubated for 5 min on ice. After 
centrifugation cleared lysates were used for analysis of luciferase and β-galactosidase 
activities. Just before measuring at the luminometer (Lumat LB9501, Berthold) 40 µl cell 
lysate were added to 300 µl luciferase buffer in the test tubes. 100 µl of luciferin solution 
were added by the luminometer to each sample. Samples were measured in duplicates. To 
quantify β-galactosidase activity 400 µl Z-buffer were added to 40 µl cell lysate. The reaction 
was started by addition of 100 µl ONPG-solution, incubated at 37°C and stopped by addition 
of 250 µl 1 M Na2CO3 when intense yellow staining was observed. Samples were measured in 
triplicates using a photometer at 405 nm. Firefly luciferase activity was normalized to 
cotransfected Renilla luciferase or LacZ activity (pRL-TK, Promega or pEQ176, Schleiss et 
al., 1991). Expression of chimeric ligands was verified by Western blot analysis. 
For the analysis of cis-inhibition, HeLa-N1 cells were cotransfected with the corresponding 
ligand pTracerCMV expression vector in addition to the luciferase constructs RBP-luc and 
pRL-TK. Expression levels of transiently expressed ligands were analyzed by Western blot 
analysis.
5x Extraction buffer: 125 mM Tris pH 7.8 (adjust pH with phosphoric acid),  
10 mM EDTA, 50% glycerine, 5% TritonX-100 
dilute 1:5 and add 10 mM DTT before use 
Luciferase buffer: 25 mM diglycine, 15 mM MgSO4, autoclave, store at 4°C 
add 5 mM ATP before use 
Z-buffer: 60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 
1 mM MgSO4, autoclave, store at 4°C  
add 35 µl β-mercaptoethanol per 10 ml buffer before use 
Luciferin stock: 25 mM luciferin in 25 mM NaOH, store at-20°C 
dilute 1:100 before use 
ONPG stock: 4 mg/ml ο-Nitrophenyl-β-galactopyranoside in Z-buffer,  
store at -20°C 
Stop solution: 1 M Na2CO3 
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3.5 Methods of embryology 
3.5.1 Mouse keeping, embryo preparation and PSM dissection 
Mice were kept and bred in the central animal facility of the Medical School Hannover. 
Timed matings were set up and females were examined daily for a vaginal plug to obtain 
mouse embryos of a known gestation stage. Noon on the day of appearance of the vaginal 
plug was designated as day 0.5 post coitum (E0.5). Embryos were dissected from the uterus 
and the Reichert’s membrane was removed under the stereomicroscope by standard 
techniques (Beddington, 1987).  
Embryos for skeletal preparations were dissected in water.  
Embryos for immunofluorescence stainings were dissected and rinsed in phosphate-buffered 
saline (PBS) and fixed overnight with 4% paraformaldehyde (PFA) in PBS.  
For PSM protein lysates, the PSM of an E9.5 embryo was dissected in PBS and cut after the 
first somite with an insect needle. Each PSM was stored separately in 20 µl 2x sample buffer 
at -80°C. For genotyping, the rest of the embryo was digested with proteinase K, genomic 
DNA was isolated and genotyped by PCR. Prior to western blot analysis the PSMs were lysed 
in a sonifier water bath for ~25 min.  
3.5.2 Whole mount immunofluorescence staining of embryos 
Embryos were dissected at E9.5, fixed in 4% paraformaldehyde/PBS overnight at 4°C, 
washed three times with PBS, dehydrated through a standard methanol/PBS series and stored 
in methanol at −20°C. Rehydrated embryos were washed three times in antigen retrieval 
solution, heated to 100°C for 10 min and allowed to cool down to room temperature. Embryos 
were washed in water and cracked for 8 min in 100% acetone prechilled to −20°C and then 
rehydrated in water. Embryos were blocked overnight in blocking solution at 4°C. Embryos 
were incubated with primary antibodies diluted in blocking solution at 4°C for 2–3 days with 
gentle agitation. Embryos were washed six times in PBS-TR for 30 min each and then 
reblocked for 1–2 h at room temperature. Fluorochrome-conjugated secondary antibodies 
PBS: 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 
1.4 mM KH2PO4, pH 7.3  
PBS-TR: 0.1% Triton X-100 in PBS 
Blocking solution: 1% BSA in PBS-TR 
Antigen retrieval solution: 10 mM sodium citrate buffer pH 6 
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were diluted in blocking solution and incubated with embryos at 4°C overnight with gentle 
agitation. The embryos were washed six times in PBS-TR for 30 min each, cleared by 
successive 10-min washes in 25% glycerol, 50% glycerol, and 70% glycerol. The posterior 
third of the embryos was dissected and flat-mounted sagittally in ProLong Gold antifade 
(Invitrogen). Texas Red- and/or Alexa Fluor®488-labeled cells were analyzed by confocal 
laser-scanning microscopy using the LSM 510 Meta (Carl Zeiss MicroImaging, Inc.) 
connected to the inverted microscope (Axiovert 200M; Carl Zeiss MicroImaging, Inc.) with a 
Plan Apochromat 63×/1.4 oil differential interference contrast objective. For image 
acquisition, LSM 510 software was used. Pictures were processed and assembled using 
Photoshop and Illustrator CS (Adobe). 
3.5.3 Skeletal preparation of E18.5 embryos 
E18.5 embryos were dissected and macerated in water for 2 h. Embryos were incubated in 
65°C warm water for 1-2 min and quenched with cold water. Afterwards embryos were 
skinned and eviscerated (inner organs were used for genotyping). Embryos were fixed in 
100% ethanol for 1-2 days. Skeletons were stained as follows: Cartilage staining was 
performed by incubating embryos in Alcian Blue cartilage staining solution for 2-3 days. 
Subsequently, embryos were washed in 100% ethanol for 2 days and tissue was digested by 
incubation for 1-5 h in 0.5% KOH. Afterwards staining of the bones by incubation in Alizarin 
Red bone staining solution for 5-16 h was performed. Embryos were digested further in 
0.05% KOH until the tissue was transparent. Skeletons were stored in 30% glycerine/0.01% 
KOH and photographed using a microscope (M420; Leica) with Apozoom 1:6 and Photo 
grab-300Z version 2.0 software (Fuji Photo Film Co.). 
 
Alcian Blue cartilage staining sol.: 150 mg/l Alcian Blue 8GX in 80% ethanol,  
20% acetic acid 
Alizarin Red bone staining sol.: 50 mg/l Alizarin Red in 0.1% KOH 
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4 Results 
At the beginning of this project little was known about the properties and functions of the 
divergent DSL protein DLL3. Initial studies in Xenopus laevis indicated that it acts as a Notch 
activator because ectopic Dll3 expression inhibited primary neurogenesis (Dunwoodie et al., 
1997). 
Given the distinct loss-of-function phenotypes of Dll3 and Dll1 null alleles, the divergent 
DSL domain and reduced number of EGF-like repeats in DLL3 the question was raised 
whether Dll3 can still functionally substitute Dll1 by its biochemical properties. To address 
this question in vitro, Dll1 and Dll3 as well as a number of mutant and chimeric ligands were 
overexpressed in cell culture, studied with respect to their subcellular localization and 
subsequently used in transactivation assays together with cells harboring a Notch-responsive 
reporter. Furthermore, in order to analyze a potential functional redundancy in vivo, a mouse 
model was generated by a targeted knock-in in which the Dll3 cDNA was expressed under the 
regulatory control of Dll1. 
4.1 DLL3 does not activate Notch signaling in vitro 
To express wildtype DLL1 and DLL3 in cell culture, the full length cDNAs were cloned into 
the eukaryotic expression vector pTracer that contains a CMV promoter driving the 
expression of the inserted coding sequence and a zeocin resistance cassette for selection. A 
flag or HA tag was added C-terminally to allow for monitoring of protein expression levels. 
Previously, it was shown that the addition of a tag at the C-terminus does not interfere with 
binding of the ligand to the Notch receptor (Lindsell et al., 1995; Oda et al., 1997; Shimizu et 
al., 2000b). 
An internal ribosomal entry site (IRES) and a neomycin resistance cassette were added 
downstream of the inserted cDNA to allow for G418-selection. Thus, in the course of 
generating stable cell lines, treatment of transfected cells with G418 should select for cell 
clones expressing the inserted cDNA and therefore facilitate the search for cell clones with 
high expression levels. However, only 5 to 50% of the G418-resistent CHO cell clones 
showed efficient expression of the inserted coding sequence as determined by Western blot 
analysis. 
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To analyze the activation of Notch by DLL1, DLL3 and their variants a transactivation assay 
(Logeat et al., 1998) was established in the laboratory and optimized. This assay was based on 
a luciferase reporter gene that was expressed under the control of a promoter containing 
RBPJκ binding sites. Activation of Notch in cells carrying such a reporter resulted in Notch-
dependent expression of luciferase. Notch activation was achieved by cocultivation of ligand-
expressing cells with Notch-expressing cells transfected with the Notch-responsive luciferase 
reporter construct. Subsequently, the cells were lysed and assayed for luciferase activity.  
A HeLa cell line stably expressing Notch1 (HeLa-N1, a kind gift of A. Israel, Institute 
Pasteur, Paris) was used for the transactivation assay. Notch1 was shown to interact with 
DLL1, Jagged1 and Jagged2 (Shimizu et al., 2000b) and is indispensable for somitogenesis. 
Accordingly, ligand interaction with Notch1 should reflect the situation in the presomitic 
mesoderm.  
Since the cell type and the design of the reporter construct as well as the ratio of Notch1- and 
ligand-expressing cells influence the overall readout of the coculture experiment, various 
assay conditions were tested to improve the sensitivity of the transactivation assay. Initially, 
two different Notch-responsive luciferase reporter constructs were used in cocultures of 
transfected HeLa-N1 cells with OP9 cells stably expressing Dll1 (kindly provided by Dr. A. 
Israel, Institute Pasteur, Paris). The Hes1 luciferase construct (Hes1-luc) consisted of the 
endogenous Hes1 minimal promoter, comprising two RBPJκ binding sites, upstream of the 
firefly luciferase coding sequence (Jarriault et al., 1995). The other reporter construct (RBP-
luc) consisted of twelve copies of the RBPJκ binding site from the EBV TP1 promotor linked 
to the beta-globin promoter upstream of the firefly luciferase coding sequence (Minoguchi et 
al., 1997). In the transactivation assay the RBP-luc vector showed more than two-fold 
stronger activation capacity than the Hes1-luc vector (Fig. 4.1 A). Therefore the RBP-luc 
construct was used as reporter in the subsequent experiments.  
With OP9 cells it proved difficult to obtain single cell suspension to precisely count cell 
numbers hence cocultivation for transactivation was tested with transfected CHO cells 
(Chinese hamster ovary cells). Since transient expression of Dll1 gave highly variable results 
in this transactivation assay due to the variance in expression levels, stable CHO cell lines 
were generated. After transfection with the respective pTracer expression construct, CHO 
cells were grown under zeocin-selection for integration and G418-selection for expression of 
the DLL1 protein. Resistant cell clones were expanded and screened by Western blot analysis 
for high expression levels of the overexpressed flag- or HA-tagged protein. After generation 
of stable CHO cell lines expressing Dll1 they were tested in the transactivation assay for their 
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Fig. 4.1: Establishment and optimization of a transactivation assay. (A) After cocultivation with OP9 cells
expressing Dll1, the transfected RBP-luc reporter construct induced Notch signaling in HeLa-N1 cells two fold 
stronger than the Hes1-luc plasmid. Transfected HeLa-N1 cells without cocultivation were set as reference. The 
vector control expressing GFP (OP9MIG) showed no transactivation. (B) CHO-Dll1 cell lines transactivated 
HeLaN1 transfected with RBP-luc reporter construct stronger than the OP9Dll1 cell line. C) A 1:1 ratio of HeLa-
N1 and CHO-Dll1 cells showed the strongest induction of Notch1 signaling via the RBP-luc reporter plasmid. 
Transfection efficiency was normalized to the activity of β-galactosidase expressed by a cotransfected CMV-
LacZ construct. Two cocultivations were performed for each experiment, bars represent standard deviations. 
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potential to induce Notch activation. The CHO-Dll1 cell line #A7 was able to induce Notch1 
activation to a considerably larger extent than the corresponding OP9 cell line (Fig. 4.1 B) and 
therefore used for further experiments. With regard to the ratio of cell numbers, a 
cocultivation with equal cell numbers of the HeLa-N1 and CHO-Dll1 cell lines showed the 
best transactivation result (Fig. 4.1 C). These settings were used in all following 
transactivation assays.  
To compare the transactivation ability of DLL3 to that of DLL1, stable cell lines were 
generated (for information concerning the CHO cell lines used for the experiments described 
in the figures of this thesis see appendix, Tab. 1). In transactivation assays DLL1 expressing 
CHO cells activated the Notch1 receptor more strongly compared to untransfected CHO cells. 
In contrast, CHO cells stably expressing DLL3 did not induce Notch1 signaling (Fig. 4.2).  
Fig. 4.2: Notch activation by DLL1 and DLL3. CHO cells stably expressing DLL1Flag strongly activated 
Notch1 signaling in with RBP-luc reporter transfected HelaN1 cells (set as 100%), while CHO cell lines stably 
expressing DLL3 did not induce Notch1 activation (DLL3HA ~1,3% ± 1,7%SD; DLL3Flag ~4,3% ± 4,1%SD). 
Untransfected CHO cells were set as 0%. Transfection efficiency was normalized to the activity of β-
galactosidase or Renilla luciferase expressed by cotransfected CMV-LacZ or pRL-TK (Promega) construct, 
respectively. Four cocultivations were performed with DLL3HA CHO cells analyzed in two independent 
experiments each, including negative and positive controls. Six cocultivations were performed with DLL3Flag 
CHO cells analyzed in three independent experiments each, including negative and positive controls. Bars 
indicate the standard deviation. For information concerning CHO cell lines see appendix, Tab. 1. 
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4.2 DLL3 is predominantly located inside the cell 
Based on the presence of a signal sequence and a transmembrane domain, all Notch ligands 
are assumed to be transmembrane proteins present on the surface of the signal-sending cells. 
Given the inability of Dll3 to activate Notch in vitro it was important to verify surface 
expression of this protein. To analyze cell surface presentation, proteins exposed on the cell 
surface of CHO cell lines were labeled with biotin. After cell lysis biotinylated proteins were 
precipitated by streptavidin and analyzed for the presence of DLL1 and DLL3, respectively, 
by western blot analysis. 
Fig. 4.3: Localization of DLL3 in 
various cell lines. Western blot analysis 
of cell lysates (input) and streptavidin-
immunoprecipitated protein after surface 
biotinylation (IP). (A) Transiently 
expressed DLL3flag protein (a-c) was not 
detected on the cell surface. On the 
surface of CHO cells, stably expressed 
DLL1flag is readily detected (IP, c) 
although expressed at lower levels than 
transiently expressed DLL3 (input, c). In 
CHO cell lines stably expressing 
DLL3flag (e) or DLL3HA (f) only low 
amounts of DLL3 were present on the cell 
surface although total protein levels were 
similar to those of cells stably expressing 
DLL1 (d). (B)  L cells coexpressing 
DLL3flag at significantly higher levels 
than DLL1HA present DLL1 efficiently 
on the surface but not DLL3 (a, d). CHO 
cells coexpressing DLL3HA and 
DLL1flag (b, c, e and f) present DLL1 
efficiently on the surface but DLL3 only 
in trace amounts.  
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Surprisingly, the analysis of the surface expression in the stable CHO cell lines revealed that 
DLL3 presentation on the cell surface was highly reduced compared to DLL1. 
In CHO and HEK293 cells with high transient DLL3 expression levels no DLL3 protein was 
present on the cell surface although DLL3 protein was readily detected in the whole cell 
lysates (Fig. 4.3 A lanes a, b). In the stable CHO-Dll1 cell line, total expression levels of 
DLL1 in the whole cell lysates were lower than those of transiently coexpressed DLL3. 
However, in contrast to DLL1, no DLL3 protein was present on the cell surface (Fig. 4.3 A, 
lane c).  
Similarly, among the CHO cell lines stably expressing DLL3 several clones exhibited no 
detectable or only minor amounts of protein on the surface. The cell line shown in Fig. 4.3 A 
lane e showed the highest presentation of DLL3 on the surface among all lines examined.  
Distinct surface expression of DLL1 and DLL3 was confirmed in CHO cells coexpressing 
Dll1 and Dll3 with different tags. Dll3 was transiently expressed in CHO cells stably 
expressing Dll1 and vice versa. In both cases, DLL1 was easily detected on the cell surface, 
while DLL3 was not, or only in trace amounts (Fig. 4.3 B b, c and e, f). The same was true for 
DLL3 surface presentation in L cells stably expressing DLL1 and transiently expressing 
DLL3 (Fig. 4.3 B a, d; L-Dll1HA cells were a kind gift of G. Weinmaster, University of 
California, Los Angeles). Even when DLL3 was detected on the surface, the relative amounts 
of DLL3 were always considerably lower than those of DLL1 (compare Fig. 4.3 B lane a with 
lanes b and c). 
To verify these differences in protein localization a second independent approach was 
pursued. Immunofluorescence stainings of CHO cells expressing either DLL1 or DLL3 or 
both were established with different antibodies to analyze the subcellular localization of the 
two DSL proteins in situ. In transiently as well as in stably expressing cells DLL1 was readily 
detected on the cell surface (Fig. 4.4 A, a-d). In some cases depending on the expression level, 
DLL1 protein was also detected in vesicular structures in the cytoplasm, but the majority of 
DLL1 protein was associated to the membrane. Occasionally, the contacting surfaces of the 
cells showed an accumulation of DLL1 protein (Fig, 4.4 A c). 
In contrast, DLL3 staining with anti-flag or anti-DLL3ICD antibodies was mainly perinuclear 
(Fig. 4.4 A e-h) and not detectable at the membrane which is consistent with the surface 
biotinylation data. Given that the flag tag recognizes the intracellular domain of DLL3 as it is 
C-terminally linked to it, stainings with antibodies against the intracellular and extracellular 
domains of DLL1 and DLL3 were compared to exclude the possibility that cleavage of the 
intracellular domain leads to protein translocation into the cell. Confocal images of these 
  Results 
  52 
stainings showed no obvious differences between the detection of the intra- and the 
extracellular protein domain (Fig. 4.4 B). 
When coexpressed, DLL1 and DLL3 colocalized in perinuclear structures but essentially not 
at the cell membrane (Fig. 4.5 A). To further investigate the subcellular localization of DLL3 
protein, costainings with organelle markers were performed. In the perinuclear region, DLL3 
partially colocalized with GM130, a marker for the cis-Golgi network. However, DLL3 
showed no colocalization with Calreticulin, a marker for the endoplasmic reticulum 
(Fig. 4.5 B).  
Taken together, these data suggest that in cells expressing DLL1 and/or DLL3, DLL1 is 
largely present on the cell surface while DLL3 localizes to perinuclear regions, including the 
Golgi apparatus. Since Notch signaling relies on the contact of proteins on the surface of 
opposing cells, the intracellular localization of DLL3 might provide a ‘trivial’ explanation for 
its failure to transactivate Notch. 
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Fig. 4.4: Detection of DLL1 and DLL3 proteins by immunofluorescence in various cell lines.  (A) In stably 
DLL1 expressing CHO cell lines (a) as well as in transiently expressing CHO (b, c) and HEK293 cells (d) DLL1 
is present on the cell surface. Dll3 is detected in perinuclear structures in stably DLL3 expressing CHO cells (e) 
and in transient expressing cells (f-h) (B) Antibodies against the extracellular domain of DLL1 (a,b) or the 
intracellular domain (c, d) show the same membrane staining. Stainings with antibodies against the extracellular 
domain (e) or the intracellular domain (f, g) as well as the intracellular tag (HA, h) all reveal DLL3 localization 
inside the cells. Scale bars, 10 µm. 
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Fig. 4.5: Colocalization studies of DLL1 and DLL3. (A) Colocalization of DLL1 and DLL3 in overexpressing 
cells. CHO cells expressing DLL1 (a and d) show a clear cell surface staining, whereas DLL3 (b and e) is 
detected almost exclusively inside the cell. DLL1 and DLL3 colocalize only in some vesicular structures (c, f 
arrowheads) but not significantly at the membrane. (B) Colocalization of DLL3 with organelle markers. DLL3 
colocalizes with the Golgi marker GM130 (f), but not with the marker for endoplasmatic reticulum, Calreticulin 
(c). Scale bars, 10 µm. 
  Results 
  55 
4.3  Endogenous DLL3 colocalizes with the Golgi-Marker 
GM130 
Up to now, subcellular localization of the DSL proteins Dll1 and Dll3 was not studied in vivo. 
To exclude that the observations in vitro could be due to high protein levels caused by 
unphysiological overexpresssion in cell culture, the localization of the endogenous proteins 
under physiological conditions was addressed by whole mount immunohistochemistry of 
wildtype mouse embryos using a technique adapted from Gavin Chapman (Victor Chang 
Cardiac Research Institute, Darlinghurst, Australia). Data were obtained by confocal laser 
scanning microscopy. Previously, it was shown by whole mount in situ hybridization that 
Dll1 and Dll3 mRNAs are coexpressed in the presomitic mesoderm of E9.5 mouse embryos. 
In addition, mRNA levels were relatively high in the PSM, qualifying this embryonic tissue to 
study the localization of DLL1 and DLL3 protein in the same cells in vivo. 
Similar to the observations obtained from cell culture experiments, endogenous DLL1 was 
predominantly present on the surface of presomitic mesoderm cells and colocalized with 
plasma membrane proteins detected by an anti-pan-Cadherin antibody (Fig. 4.6  a-c). In 
addition some intracellular DLL1 was detected that colocalized mainly with the Golgi matrix 
protein GM130 (Fig. 4.6 f).  
Importantly, endogenous DLL3 was not detected at the membrane of PSM cells (Fig. 4.6 l). 
Two different polyclonal antibodies (C2 against the C terminus/intracellular domain or N2 
against the N terminus/extracellular domain of DLL3) showed the same protein localization 
(data not shown) excluding that cleavage of the protein leads to different localization of extra- 
and intracellular domain of DLL3. 
DLL3 was detected in intracellular regions largely overlapping with the cis-Golgi marker 
GM130 (Fig. 4.6 m-o), indicating that the localization of DLL3 in the Golgi network 
observed in overexpressing cells occurs also in vivo. Both DSL proteins colocalized in some 
intracellular areas but were otherwise essentially not overlapping (Fig. 4.6 g-i). Given that 
Notch ligands need to be present at the cell surface for Notch activation, together with the 
results from the transactivation assay the findings suggested that DLL3 does not serve as an 
activating Notch ligand as it is accumulated in the Golgi network under physiological 
conditions and only minor amounts of DLL3, if any, are present on the surface of presomitic 
mesoderm cells. 
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Fig. 4.6: Localization of endogenous DLL1 and DLL3 proteins. Immunofluorescent detection of DLL1 and 
DLL3 in PSM cells of E9.5 embryos. Endogenous DLL1 is present at the surface (a) and colocalizes with the 
membrane (c) and in vesicular structures with the cis-Golgi marker GM130 (f). DLL3 does not colocalize with 
anti-pan-Cadherin staining of the membrane (l) but is detected in vesicular structures in the cytoplasm (m), 
mostly overlapping with GM130 (o). DLL1 and DLL3 colocalize inside the cell but not at the membrane (i).
Scale bars, 10 µm. 
  Results 
  57 
4.4 Generation of Dll3 knock-in alleles 
In parallel to the in vitro experiments, a replacement of Dll1 by tagged and untagged Dll3 was 
approached in vivo. The Dll1 locus was targeted by homologous recombination in ES cells in 
order to generate mutant mice. The rational behind this strategy was to analyze whether Dll3 
can rescue Dll1 function under physiological conditions.  
A knock-in of a “minigene” version of Dll1 into the Dll1 locus was previously generated 
(Schuster-Gossler et al., 2007). Mice carrying this allele were viable and showed no obvious 
phenotype indicating that the alteration of the Dll1 locus had no adverse effects on expression 
of the Dll1 minigene.  
The strategy for targeting the Dll1 locus by a Dll3 knock-in (Dll1Dll3ki) was adopted from a 
strategy developed by Dr. Ralf Cordes (Schuster-Gossler et al., 2007).The Dll1 locus consists 
of eleven exons with the open reading frame starting at the end of the first exon. A chimeric 
Dll3 “minigene” was fused in frame to the start-of-translation codon (ATG) of the 
endogenous Dll1 gene, analogous to the Dll1lacZ-null allele generated previously by Hrabe de 
Angelis et al. (1997). Thereby, the Dll3 coding region was expressed under the control of the 
regulatory elements of the Dll1 gene and Dll1 function was simultaneously eliminated. In the 
Dll3 minigene, the Dll3 coding sequence was linked at the 3’end to genomic sequences of the 
Dll1 gene containing exons 9–11 (Fig. 4.7 A) and including the 3’UTR that provides the 
polyadenylation signal. After processing of the primary transcript, the Dll3 coding sequence 
was thus flanked by the 5’ and 3’ UTRs of Dll1, which should generate Dll3 transcripts with 
stability and processing properties similar to those of the genuine Dll1 mRNA. The Dll3 
cDNA is expected to be expressed in the same spatially and temporally regulated pattern as 
Dll1 since in heterozygous Dll1lacZ mice LacZ expression reflects Dll1 expression in all 
tissues analyzed (Beckers et al., 1999; Beckers et al., 2000). 
A hemagglutinin (HA) epitope tag followed by three stop codons was included at the 
carboxyterminal end of Dll3 coding sequence to monitor expression of the exogenous DLL3 
protein. Lindsell et al. showed 1995 that the addition of a C-terminal epitope tag to the Jagged 
protein does not interfere with its function in vivo. As a control an untagged version of the 
Dll3 knock-in construct was generated to exclude that phenotypes in the Dll1Dll3HAki mice 
might attribute to the included HA tag.  
A phosphoglycerine kinase (PGK) promoter driven neomycin resistance cassette flanked by 
loxP sites was introduced 3’ to the Dll3-Dll1 fusion as a positive selection marker. Following 
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expression of Cre recombinase this selection cassette was excised. The removal of the 
PGK-neo cassette is essential for achieving physiological expression levels of the exogenous 
DLL3 since it was shown that the Dll1Dll1ki allele still carrying the PGK-neo cassette 
represents a hypomorphic allele of Dll1 (Schuster-Gossler et al., 2007). 
Diphtheria toxin A expression cassettes were included upstream and downstream of the 
homologous regions as negative selection markers to enrich for homologous recombination 
events by ablation of ES cell clones with an incomplete recombination.   
Linearized vector DNA was electroporated into 129Sv/ImJ embryonic stem cells and G418-
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Fig. 4.7: Generation of Dll1Dll3HAki and Dll1Dll3ki mice. (A) Targeting strategy for introduction of Dll3 into the 
Dll1 locus. White and black boxes indicate noncoding and coding regions, respectively. The blue box indicates 
Dll3 or Dll3HA cDNA, respectively. PCR primers align to the neo cassette and to the fifth intron, DNA probes 
for Southern blot analysis lie outside the homologous regions. Neo, PGK-neomycin resistance cassette. DT, 
diphtheria toxin A chain. (B) PCR-screening of ES cell clones for homologous recombination. Example for a 
PCR-positive ES cell clone (tg/+) showing a 4kb PCR product. (C) Screening for correctly targeted ES cell 
clones by Southern blot analysis. The targeted allele shows a 6.5kb band (3’probe) or a 5.5 kb band (5’probe) 
whereas the wildtype allele displays a 10 kb band (both probes). 
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resistant ES cell clones were selected by Dr. Karin-Schuster-Gossler and Hannelore 
Burkhardt. Targeted clones (10 out of 480 analyzed DLL3HAki) were identified by PCR using 
primers derived from the neomycin sequence and genomic sequences downstream of the 
targeting vector (Fig. 4.7 B). PCR-positive clones were further verified by Southern blot 
analysis. For this purpose genomic DNA isolated from the ES cells was digested with the 
restriction enzyme BamHI, separated by gel electrophoresis and blotted on nylon membranes. 
Two external probes located 3’ and 5’ to the regions of homology in the vector (Fig. 4.7 C) 
were used to examine the integrity of the mutated Dll1 locus in these ES cell clones. The 
diagnostic bands were at 5.5 kb (5’ probe) and 6.5 kb (3’ probe) for the targeted allele and at 
10 kb (both probes) for the wildtype allele. Correctly targeted ES cell clones were used for 
blastocyst injection (performed by Dr. Karin Schuster-Gossler) to generate chimeric mice and 
germline transmission of these alleles was obtained. After the excision of the neo cassette, 
analysis of the knock-in mice (performed by Dr. Katrin Serth) demonstrated that similar to the 
in vitro findings, Dll3 did not activate Notch in vivo (Geffers et al., 2007). 
4.5 Analysis of Notch activation in the presomitic 
mesoderm of Dll3 mutant mice 
Based on the idea that the loss of Dll3 function should lead to an increase in Notch activation 
if Dll3 served as a direct antagonist of Notch signaling (Ladi et al., 2005), protein levels of 
Dll3pudgy/pudgy wildtype Dll1
Dll3HA
95 kDa
cleaved
Notch1
/Dll3HA
Fig. 4.8: Protein levels of activated NotchICD in the presomitic mesoderm. Cell lysates of a single 
presomitic mesoderm (PSM) of E9.5 wildtype, pudgy and Dll1Dll3HA embryos were loaded. Western Blot analysis 
was performed with an anti-cleaved Notch1 antibody (Val1744). In homozygous Dll3pudgy PSMs the levels of 
activated NotchICD were slightly lower than in wildtype PSMs. In PSMs of homozygous Dll1Dll3HA embryos 
very weak bands of cleaved Notch were detected. Arrowhead indicates the expected 110 kDa band of NotchICD. 
The second band is presumably unspecific detection by the antibody. 
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activated Notch were assessed by Western blot analysis of the presomitic mesoderm (PSM) of 
E9.5 pudgy, wildtype and Dll1Dll3HAki/Dll3HAki embryos (provided by Dr. Katrin Serth). PSMs 
were dissected, lysed in protein sample buffer and analyzed with antibodies against cleaved 
Notch1. The protein levels of activated Notch intracellular domain in the presomitic 
mesoderm of pudgy embryos were even slightly lower than in wildtype mice refuting a direct 
antagonistic function of DLL3 (Fig. 4.8). In the presomitic mesoderm of Dll1Dll3HAki/Dll3HAki 
embryos only very little cleaved Notch1 was detected. 
4.6 DLL1 domains required for Notch activation 
In vitro experiments revealed the intracellular localization of DLL3 and its inability to 
activate Notch indicating that DLL3 is not a bona fide Notch ligand. The DLL1 and DLL3 
proteins show several differences in their amino acid sequences that might contribute to the 
functional non-equivalence of the two DSL proteins. Compared with DLL1, the DLL3 protein 
has a deviant DSL domain, fewer EGF-like repeats, and altered spacing between some EGF-
like repeats. It also lacks lysine residues and a PDZ ligand binding domain in its intracellular 
domain. 
To analyze which of these structural differences might contribute to the functional divergence, 
various chimeric ligands were generated by combination of different protein domains of 
DLL1 and DLL3 using PCR and site-directed mutagenesis without altering, deleting or 
inserting amino acids. All these C-terminally tagged chimeric Dll1-Dll3 cDNAs (Fig. 4.9 A) 
were cloned into the pTracer vector for cell culture expression and establishment of stable 
CHO cell lines. Cell lines were analyzed for protein expression levels by Western blot 
analysis to identify clones expressing similar levels of different protein variants for further 
analyses. (Some constructs and the cell lines used for Notch activation assays were generated 
and analyzed by Dr. Katrin Serth as specified in chapter 3.2.2, page 29 and appendix Tab. 1) 
Cell surface localization of chimeric proteins was assessed by surface biotinylation, followed 
by immunoprecipitation and Western blotting. Chimeric ligands A–H were readily detected 
on the cell surface though to different extents (Fig. 4.9 B). Comparing total protein levels 
(Fig. 4.9 B, input) with amounts on the surface (Fig. 4.9 B, IP), chimeric ligands B, D, E, F 
and H showed surface protein levels similar to DLL1, whereas chimeras A, C and G exhibited 
a diminished cell surface presentation. 
However, only constructs C and G let to significant activation of Notch indicating that EGF–
like repeats 3-6 of DLL3 are functionally equivalent to EGF-like repeats 5-8 of DLL1 as 
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assumed by their high sequence homology. Furthermore, the N-terminus including the DSL 
domain and EGF-like repeats 1 and 2 in combination with the intracellular domain of DLL1 
are essential and sufficient to activate Notch1 (Fig 4.9 A; final transactivation assays 
performed by Dr. Katrin Serth are published in Geffers et al., 2007). 
 
Fig. 4.9: Analysis of DLL1-DLL3 chimeric ligands. (A) Schematic overview of wildtype DLL1 and DLL3 and 
chimeric constructs used to generate stably expressing CHO cell lines. DLL1 protein is shown in black and 
DLL3 in red. Numbers indicate the amino acid residue numbers. DSL, DSL domain; E1–E8, EGF-like repeats; 
the flag tag is indicated by white ovals and the HA tag in construct H by a black oval. Corresponding EGF-like
repeats of DLL1 and DLL3 are connected by black lines. The levels of Notch transactivation induced by the 
chimeras are indicated as follows: +++: very strong; ++: strong; +: weak; -: none. Transactivation results 
obtained by Dr. Katrin Serth are marked with *. (B) Western blot analysis of cell lysates (input) and streptavidin 
immunoprecipitated protein after surface biotinylation (IP). CHO cells stably expressing chimeric ligands show 
similar (input A and B) or even stronger (input C–H) expression compared with DLL1 expressing cells. All 
chimeric ligands are present on the cell surface (IP), chimeric ligands A, C, and G at lower levels and chimeric 
ligands B, D–F, and H at similar or even higher levels compared to DLL1. 
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4.7 Protein domains affecting subcellular localization 
The surface biotinylation results suggested that chimeric ligands differ with respect to their 
propensity to localize to the surface. To analyze in more detail how different protein domains 
of DLL1 and DLL3 affect the distribution of the stably overexpressed chimeric ligands in the 
cell, their localization on the cellular level was studied by indirect immunofluorescence 
(Fig. 4.10). Additional chimeras were cloned and cell lines thereof generated to narrow down 
the region required for cell surface presentation of DLL1 and intracellular localization of 
DLL3 (Fig. 4.10 A, chapter 3.2.2 and appendix, Tab. 1).  
Chimeric ligands containing the transmembrane and intracellular domain (TM-ICD) of DLL1 
and at least the DLL1 N-terminus including the DSL domain fused to extracellular DLL3 
sequences were detected on the cell surface in addition to variable intracellular expression 
(Fig. 4.10 B c -e).  
Though haboring the DLL1 signal peptide, chimeric ligands containing only the N-terminus 
of DLL1 linked to DSL domain and EGF repeats of DLL3 (chimeras J and M) were 
exclusively detected in intracellular regions (Fig. 4.10 B f, k). The same was true for a 
chimera consisting of the DLL3 extracellular domain juxtaposed to the DLL1 TM-ICD (Fig. 
4.10 B g). As the intracellularly truncated version of DLL1 (ligand H) was predominantly 
detected on the surface, the intracellular domain of DLL1 appeared to be dispensable for 
surface expression (Fig. 4.10 B b). Taken together, these findings demonstrate that the DSL 
domain of DLL1 is necessary to direct cell surface presentation of chimeric proteins. 
In contrast to cells expressing DLL1 or construct H or B, that consistently showed strong  
expression on the surface, surface presentation of most chimeric ligands containing a 
combination of DLL1 and DLL3 domains in their extracellular part was variable and not 
detectable in all expressing cells. Especially chimeric ligands C and G exhibited variable 
surface staining. Furthermore, chimeric ligands containing the transmembrane domain and the 
juxtaposed sequences of DLL3 were predominantly found in intracellular regions (Fig. 4.10 B 
i-k) as a result of a strongly diminished cell surface presentation compared to chimeras with 
the corresponding Dll1 sequences.  
Collectively, it appears that while the DLL1 DSL domain is required for cell surface 
presentation, the DLL3 transmembrane domain together with adjacent sequences is involved 
in retention of chimeric ligands in intracellular compartments and localization of DLL3 to the 
Golgi network. 
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Fig. 4.10: Localization of chimeric DLL1 and DLL3 proteins. (A) Schematic representation of chimeric 
proteins containing the ICD of DLL1 (left) or DLL3 (right) arranged according to the extent of extracellular 
DLL1 sequences (top to bottom). Gray parts and red parts indicate DLL1 and DLL3 sequences, respectively. 
White filling indicates DSL domains, light gray or red shading indicates TMs, and filled boxes indicate EGF-like 
repeats. (B) Confocal images of CHO cells expressing chimeric ligands and stained by indirect 
immunofluorescence. Similar to DLL1 (a) and DLL1 lacking the ICD (b), chimeric ligands that contained the 
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TM-ICD of DLL1 and the DLL1 N-terminal portion including the DSL domain were detected on the cell surface 
(c–e), in addition to some variable intracellular expression. Presence of the DLL1 N-terminus alone was not 
sufficient to direct detectable surface expression (f), similar to the extracellular domain of DLL3 fused to DLL1 
TM-ICD (g). Surface presentation of a chimera containing the DLL1 extracellular domain juxtaposed to the 
DLL3 TM-ICD (h). Chimeras that contain the DLL1 N-terminal portion including the DSL domain, and the 
DLL3 TM in the context of juxtaposed DLL3 sequences were retained intracellularly (i and j). Intracellular 
localization of DLL3 with the N-terminus replaced by the corresponding DLL1 sequence, and of DLL3, 
respectively (k and l). A–C, G, and H refer to chimeras shown in Fig. 4.9 A and I–M to additional ones. Chimera 
H (b) was detected with anti-DLL1 and all other chimeras with anti-flag antibodies. Scale bar, 10 µm. 
4.8 Mutations in the DSL domain of DLL1 abolish its 
transactivation potential 
In addition to the analysis of larger protein domains, differences in the DSL domain of DLL1 
and DLL3 were analyzed in more detail. The conserved DSL domain of DLL1 is essential for 
Notch binding (Shimizu et al., 1999) and appears to be necessary for surface presentation. 
The DSL domain of DLL3 is highly dissimilar to DSL domains of other Delta and Serrate 
homologues (Fig. 4.11). It lacks two conserved amino acid motifs, a YY motif (aa 182-183 in 
mDLL1) and a GWxG motif (aa 214-217 in mDLL1) and shows a different spacing between 
the conserved cysteine residues that contribute to the secondary structure of the domain by 
forming disulfide bonds. 
These two conserved motifs were mutated in DLL1 to analyze the relevance of these features 
for subcellular localization of the protein and Notch transactivation (Fig. 4.11). The double 
tyrosine motif (Y182, Y183) was mutated in DLL1 by site-directed mutagenesis into alanine 
and valine (DLL1 DSL-∆Y) to mimic the corresponding sequence of the DLL3 DSL domain. 
In a different construct the GWxG motif of DLL1 (aa 214-217) was mutated into four 
alanines (DLL1 DSL-∆G). These mutant DLL1 coding sequences were coupled to a flag tag 
and cloned into the expression vector pTracer and stable CHO cell lines were generated 
overexpressing the mutant protein. 
Cell surface biotinylation experiments were performed in order to verify cell surface 
presentation of the mutant proteins. While the DLL1 DSL-∆G mutant protein was readily 
detected on the cell surface, only trace amounts of the DLL1 variant with the deleted double 
tyrosine motif (DLL1 DSL-∆Y) was present on the cell surface (Fig. 4.12). 
The first tyrosine residue (Y182 in DLL1) seems to be required for Notch signaling as it is 
perfectly conserved even in Notch ligands of C.elegans exhibiting a histidine or phenylalanine 
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Fig. 4.12: Cell surface presentation of 
DLL1 DSL mutant proteins. Western blot 
analysis of cell lysates (input) and 
streptavidin immunoprecipitated protein 
after surface biotinylation (IP). DLL1 DSL 
mutant proteins ∆G, AY and FY were 
readily detected on the cell surface, whereas 
only very low amounts of DLL3 and 
DLL1 DSL-∆Y were detected in the 
streptavidin-precipitated fraction. 
Fig. 4.11: Alignment of the DSL domains of various Delta homologues. DLL3 shows a divergent DSL 
domain with an altered spacing of the conserved cysteine residues (bold, black) and lacks two conserved amino 
acid motifs (bold, red). Designations of the generated DLL1 DSL mutants with altered amino acid sequence are 
shown below. 
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substituting for the second tyrosine (Y183). Mutations of the first tyrosine leaving the second 
tyrosine unaffected (DLL1 DSL-AY and DLL1 DSL-FY, generated by Claudia Brockmeyer 
during her diploma thesis) resulted in apparently normal surface localization of the proteins 
(Fig. 4.12). To confirm these findings immunofluorescence stainings were performed to 
analyze the subcellular distribution of the proteins (Fig. 4.13). As expected, DLL1 DSL-∆Y 
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Fig. 4.13: Subcellular locali-
zation of DLL1 DSL mutant 
proteins with different anti-
bodies. Mutations of the 
conserved tyrosine motif in the 
DSL domain of DLL1 leads to 
altered protein localization. 
Conservative mutations to 
hydrophobic amino acids retain 
normal cell surface presentation 
ability (m-o, p-r) while surface 
presentation is completely lost 
when tyrosines were mutated to 
alanine and valine (d-f) 
Arrowheads in (e) indicate the 
membrane which shows no 
staining. Semi-conservative 
mutations of only one tyrosine 
to alanine or of both tyrosines 
to hydrophobic phenylalanines 
diminish protein amounts 
present on the cell surface (j-l, 
s-u). A similar effect has the 
mutation of the GWxG motif 
into alanines (g-i).  
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mutant protein was only detected in some perinuclear structures and did not reach the cell 
surface (Fig. 4.13 d-e). In some cases DLL1 DSL-∆Y mutant protein was detected even in the 
whole cell except for the membrane which could be recognized as a black non-fluorescent 
line (Fig. 4.13 e, arrowheads).  
DLL1 DSL-∆G and DLL1 DSL-AY mutant proteins reached the cell surface although 
overexpressed protein was also detected to a large extent in the perinuclear region (Fig. 4.13 
g-i and j-l). The conservative mutation DLL1 DSL-FY had no influence on protein 
localization as demonstrated by a surface staining similar to that of DLL1 (Fig. 4.13 m-o).  
Two additional mutations DLL1 DSL-YF and DLL1 DSL-FF were cloned to in more detail 
investigate if the presence of an aromatic amino acid residue is sufficient for protein 
localization at the cell surface. Both proteins were present on the cell surface but DLL1 DSL-
FF protein was additionally detected inside the cell (Fig. 4.13 p-r and s-u). 
In colocalization studies with organelle markers DLL1 DSL-∆Y staining partially overlaped 
with staining for the Golgi marker GM130 but hardly with calreticulin, a marker for the 
endoplasmic reticulum (Fig. 4.14) indicating that the subcellular localization of DLL1 DSL-
∆Y protein seems to be similar to that of DLL3. 
To further explore the significance of the DSL mutations for Notch activation, CHO cell lines 
stably expressing the DLL1 DSL mutant proteins were analyzed in a transactivation assay for 
their potential to activate Notch. For two DLL1 variants (DLL1 DSL-FF and DLL1 DSL-YF) 
no clonal CHO cell lines existed which is a prerequisite for reproducible protein expression 
levels, thus transactivation assays were not performed. Because of the intracellular 
mergeα GM130α DLL1
DLL1 DSL-∆Y / GM130
a b c
mergeα Calreticulinα flag
DLL1 DSL-∆Y / Calreticulin
d e f
Fig. 4.14: Colocalization of 
DLL1 DSL-∆Y protein with 
organelle markers. DLL1 
DSL-∆Y does hardly 
colocalize with calreticulin, 
an endoplasmic reticulum 
marker, (c), but localizes 
partially to the Golgi 
apparatus stained by the cis-
Golgi marker GM130 (f). 
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localization of DLL1 DSL-∆Y mutant protein, the failure of this DLL1 variant to transactivate 
Notch did not allow one to draw conclusions concerning the relevance of the double tyrosine 
motif for Notch activation. However, the DLL1 DSL-∆G mutant protein showed no 
transactivation potential although the protein was efficiently presented at the cell surface as 
determined by surface biotinylation (Fig. 4.15). Similarly, the mutations of the first tyrosine 
created DLL1 v ersions that exhibited a considerably diminished transactivation potential. 
Collectively, the mutation of the tyrosine182 or the GWxG motif in the DSL domain of DLL1 
led to an abolishment of DLL1 function. Additionally, the presence of two hydrophobic 
amino acids with at least one tyrosine is necessary in the DLL1 DSL domain to result in 
normal cell surface presentation. 
Fig. 4.15: Activation of Notch by DLL1 DSL mutant proteins. Transactivation assay by cocultivation of 
HeLa-N1 cells transfected with the RBP-luc reporter construct and CHO cells stably expressing DLL1, DLL3 or 
DLL1 DSL mutant protein. All examined DLL1 DSL mutant protein exhibit no or a strongly diminished Notch 
activation potential. CHO cells were set to 0%, luciferase activity induced by DLL1 was set to 100%. 
Transfection efficiency was normalized to the activity of Renilla luciferase expressed by a cotransfected pRL-
TK construct (Promega). Four cocultivations were performed in two independent experiments each, including 
negative and positive controls. Bars indicate the standard deviation. For information concerning CHO cell lines 
see appendix, Tab. 1. 
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4.9 Cis-inhibition of Notch by DLL1 variants carrying a 
mutated DSL domain  
Interactions of Notch receptors with coexpressed Notch ligands in the same cell were 
previously shown to result in an impairment of Notch signaling (de Celis and Bray, 2000; 
Jacobsen et al., 1998). In vertebrates (chick), this cis-inhibition has been demonstrated for 
Serrate and Delta homologues (Sakamoto et al., 2002). Recently, coculture luciferase assays 
revealed a cis-inhibitory function for DLL3 although it cannot activate Notch (Ladi et al., 
2005).  
As the DLL1 DSL mutant proteins have lost their transactivation capacity and some of them 
showed diminished cell surface presentation, the question was raised whether these effects 
also influence their ability to cell-autonomously inhibit Notch transactivation by cis-
interactions.  
When coexpressed in Notch1-expressing cells, the DLL1 mutant proteins showed cis-
inhibitory effects on Dll1-induced Notch signaling to different extents (Fig. 4.16 A).  
Coexpression of high levels of DLL1 wildtype protein showed the strongest Notch1 inhibition 
(Fig. 4.16 B). Although the DLL1 DSL-∆G expression level was similar to that of DLL1, this 
DLL1 version exhibited less effective inhibition of Notch signaling. Compared to the DLL1 
DSL-∆G variant, the DLL1 DSL-∆Y mutant protein showed a similar inhibitory effect but 
was expressed at a significantly lower level indicating that its potential to inhibit Notch 
activation was actually stronger than that of the DLL1 DSL-∆G mutant protein. Taken 
together these results suggest that transactivation of Notch by ligand binding and cis-
inhibition of Notch by its interaction with coexpressed ligands in the same cell occur by two 
different modes and presumably require different regions of the ligands as interaction sites. 
Thus, dysfunction of Notch activation does not necessarily abolish the ability of DSL proteins 
to interfere with Notch in cis. 
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Fig. 4.16: Cis-inhibition of DLL1 DSL mutant proteins. (A) HeLa-N1 cells were cotransfected with RBP-luc 
plasmid and a ligand expression vector or empty vector (mock). Each transfected HeLa-N1 sample was 
cocultured with CHO-DLL1 cells and CHO wildtype cells, respectively. Within each set-up, luciferase activity 
was measured against negative control (CHO wild-type cells) set to 0%, HeLa-N1 without coexpressed ligands 
(N1+mock) was set to 100%. Expression levels of the transiently expressed proteins are shown in (B). All DSL 
protein variants showed a cis-inhibitory effect on Notch activation. DLL1 showed the strongest inhibition, DLL1 
DSL-∆Y and DLL1 DSL-∆G exhibited the weakest effect. (B) Western blot analysis of transfected HeLaN1 
cells used for transactivation assay in (A). Protein expression levels of the cotransfected ligands were analyzed 
by Western blot of whole cell lysates with anti-flag antibodies. 
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4.10 Tyrosine O-sulfation of DLL1 is not detectable 
The double tyrosine motif in the DSL domain is highly conserved in Delta homologues from 
Drosophila melanogaster to humans. Organisms that emerged earlier during evolution - like 
the nematode C. elegans or the green sea urchin - contain only the first tyrosine and another 
aromatic amino acid at the corresponding position in the DSL domain of Notch ligands 
(Fig. 4.11, C.elegans Notch ligands Apx-1 and Lag-2). The presence of this tyrosine motif 
might have potential importance for different processes. Given that the tyrosines are in the 
extracellular part of the DLL1 protein modifications such as tyrosine phosphorylation are 
unlikely to occur as they were described only for cytoplasmic parts of proteins.  
In a search for modification sites in DLL1 the double tyrosine motif in the DSL domain of 
DLL1 was predicted to serve as a sulfation site. Tyrosine O-sulfation is a post-translational 
modification of proteins synthesized along the secretory pathway (Moore, 2003). In the Golgi 
apparatus, the tyrosylprotein sulfotransferases catalyze the transfer of sulfate from the 
universal sulfate donor adenosine 3’-phosphate 5’-phosphosulfate (PAPS) to the hydroxyl 
group of a peptidyltyrosine residue (Lee and Huttner, 1983). The general effect of this 
modification seems to be enhancement of protein-protein interaction (Wilkins et al., 1995). 
Additionally, sulfation may have an impact on protein trafficking (Friederich et al., 1988). 
Although common features for tyrosine O-sulfation have been described, there is no 
consensus sequence per se (Moore, 2003). 
Fig. 4.17: Tyrosine O-sulfation. (A) Western Blot analysis after immunoprecipitation of DLL1 and PSGL-1 
with anti-DLL1 (1F9) and anti-PSGL-1 antibodies, respectively. (B) Radiograph of [35S]-labeled protein of CHO 
cells expressing DLL1 or PSGL-1 and of CHO control cells after immunoprecipitation of the respective protein 
(see A). No [35S]-labeled DLL1 band was detetected. 
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To investigate this potential modification of DLL1 protein, metabolic labeling of CHO cells 
expressing Dll1 was performed with [35S]-sulfate. As a positive control P-selectin 
glycoprotein-1 (PSGL-1) which can be sulfated on a cluster of three tyrosine residues was 
labeled in CHO cells (Liu et al., 1998). Afterwards the cells were lysed and protein lysates 
were subjected to immunoprecipitation by addition of protein G sepharose and antibodies 
against DLL1 and PSGL-1, respectively. 
After separation of the precipitated protein fractions by SDS-PAGE the gels were exposed for 
three weeks. The positive control (PSGL-1) showed bands of the expected size indicating that 
the metabolic labeling procedure was successful. Although DLL1 was readily obtained by 
immunoprecipitation of protein lysates (Fig. 4.17 A) no [35S]-labeled protein band was 
detected (Fig. 4.17 B). So far, there is no evidence of tyrosine O-sulfation of Dll1. 
4.11 Generation and analysis of Dll1 DSL mutant mice 
Parallel to the in vitro experiments, two of the generated DLL1 DSL mutations were analyzed 
in vivo by generation of Dll1 DSL mutant mice. Pursuing the same targeting strategy as for 
the Dll3 knock-in mice endogenous Dll1 sequence was substituted by a Dll1 minigene 
containing mutated DSL domain sequence (Fig. 4.18 A). Linearized vector DNA was 
electroporated into 129Sv/ImJ embryonic stem cells and G418-resistant ES cell clones were 
selected by Dr. Karin-Schuster-Gossler and Hannelore Burkhardt. Targeted clones were 
identified by PCR using primers derived from the neomycin sequence and genomic sequences 
downstream of the targeting vector. PCR-positive clones were further verified by Southern 
blot analysis. Two external probes located 3’ and 5’ to the regions of homology in the vector 
were used to examine the integrity of the mutated Dll1 locus in these ES cell clones. The 
diagnostic bands were at 5.5 kb (5’ probe) and 6.5 kb (3’ probe) for the targeted allele and at 
10 kb (both probes) for the wildtype allele (Fig. 4.18 B). Correctly targeted ES cell clones 
were used for blastocyst injection (performed by Dr. Karin-Schuster-Gossler) to generate 
chimeric mice and germline transmission was obtained. After excision of the neo cassette 
verified mice were used for further analyses. Heterozygous Dll1Dll1DSLmut mice showed no 
apparent phenotype demonstrating that the DLL1 DSL mutant proteins do not exert an 
obvious dominant negative function in vivo. 
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Homozygous Dll1Dll1DSLmut embryos showed similar somite formation defects as Dll1 null 
embryos and died around E11.5 due to severe hemorrhagic bleedings indicating that the 
mutations Dll1DSL-∆Y and Dll1DSL-∆G both create functional Dll1 null alleles 
(Fig. 4.18 C). The failure of the Dll1Dll1DSLmut alleles to rescue the DLL1 function confirmed 
the results obtained in vitro.  
The Dll1DSL-∆Y mutation resembles the DLL3 DSL domain which also lacks the double 
tyrosine motif. Additionally, DLL1 DSL-∆Y and DLL3 are both hardly detectable on the cell 
surface but colocalize partially with the Golgi marker GM130. These similarities raised the 
question if retention of DLL1 DSL-∆Y protein inside the cell results in a functional 
substitution of Dll3 in Dll3 mutant mice. To address this question mice double heterozygous 
Fig. 4.18: Screening for targeted ES cell clones and phenotype of E10.5 Dll1Dll1DSLmut embryos. (A) Targeted 
locus for the Dll1Dll1DSLmut knock-in. The green box indicates the Dll1 DSL-∆Y and Dll1 DSL-∆G cDNA, 
respectively. (B) Correctly targeted ES cell clones showed a shift from 10 kb to 6,5 kb with the 3’ probe and a 
shift from 10 kb to 8 kb with the 5’ probe on a Southern blot. (C) Homozygous E10.5 Dll1Dll1 DSL-∆Y(a) and 
Dll1Dll1 DSL-∆G (b) mutant embryos showed hemorrhagic bleeding and lack somite borders. The same phenotype 
was detected in Dll1Dll1 DSL-∆Y/Dll1LacZ (c) and in Dll1Dll1 DSL-∆G/Dll1LacZ (d) embryos.  
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for the Dll1Dll1DSL∆Y and the Dll3pudgy allele were intercrossed with heterozygous Dll3pudgy 
mice. If the mutated DLL1 protein could (partially) rescue the loss of DLL3 in the presomitic 
mesoderm a milder phenotype than the pudgy phenotype would be expected in mice with 
Dll1Dll1DSL∆Y/+; Dll3pudgy/pudgy genotype. Skeletal preparations of E18.5 embryos with this 
genotype showed a severely perturbed vertebral column similar to the Dll3pudgy phenotype 
(Fig. 4.19). This finding indicated that retained DLL1 DSL-∆Y protein inside the cell cannot 
substitute for Dll3 function. Thus, forced retention of a DSL protein within the cells is not 
sufficient to adopt Dll3 function in vivo. 
 Genotype Phenotype Embryos at E18.5 (Σ 41) 
  Dll1+/+; Dll3+/+ wildtype 5 
  Dll1+/+; Dll3pudgy/+ wildtype 13 
  Dll1Dll1DSL∆Y/+; Dll3+/+ wildtype 6 
  Dll1Dll1DSL∆Y/+; Dll3pudgy/+ wildtype 12 
  Dll1+/+; Dll3pudgy/pudgy pudgy 4 
  Dll1Dll1DSL∆Y/+; Dll3pudgy/pudgy similar to pudgy 1 
 
wildtype Dll3pu/pu Dll1Dll1DSL∆Y/+; Dll3pu/pu Fig. 4.19: Skeletal preparations 
of E18.5 embryos. Alcian blue 
staining of the cartilage and 
alizarin red staining of the bones. 
Homozygous pudgy embryos 
display a severely perturbed 
vertebral column with rib 
malformations. Dll1Dll1DSL∆Y/+; 
Dll3pudgy/pudgy embryos exhibit 
similar defects of the skeleton. 
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5 Discussion 
The DSL proteins Dll1 and Dll3 are coexpressed in the presomitic mesoderm but their null 
alleles display distinct phenotypes. As the two proteins additionally differ on the amino acid 
level it could be presumed that these two DSL proteins exert different functions and cannot 
compensate for the loss of each other. This study addresses the biochemical and functional 
properties of the Notch ligands DLL1 and DLL3.  
5.1 Unanticipated subcellular localization of DLL3 
Based on the fact that DLL3 carries a signal peptide and a transmembrane domain and on the 
findings that ectopic expression of Dll3 in Xenopus laevis led to Notch activation (Dunwoodie 
et al., 1997), it was assumed that DLL3 is a bona fide Notch ligand. During the course of this 
study, it was demonstrated that DLL3 did not activate Notch1 in transactivation assays (Ladi 
et al., 2005). Consistent with the inability of DLL3 to induce Notch signals DLL3 expressing 
cells did not suppress myogenic differentiation in C2C12 cells. Additionally, the authors 
demonstrated that in cells coexpressing Dll1 and Dll3, the presence of DLL3 did not perturb 
DLL1-induced Notch signaling. Ladi et al. (2005) suggested that Dll3 acts in an antagonistic 
fashion as coexpression of Dll3 with Notch inhibits Notch activation. Furthermore, they 
showed that DLL3 cannot bind to Notch in trans although DLL3 protein was verified to be 
present on the cell surface. They concluded that the inability of DLL3 to bind Notch in trans 
gives rise to its failure to activate Notch.  
In this project it was confirmed that DLL3 does not activate Notch in trans but that an 
unanticipated intracellular localization of DLL3 presumably accounts for this deficiency. 
These observations were contradictory to results published by Ladi et al. (2005) that by 
surface biotinylation demonstrated that DLL3 and DLL1 are both present to the same extent 
on the cell surface of L cells (mouse fibroblasts). This discrepancy was corroborated by 
independent lines of evidence in this study. By cell surface labeling of overexpressing CHO 
cells only trace amounts of DLL3 were found on the cell surface. Even a close recapitulation 
of the cell surface labeling experiments done by Ladi et al. (2005) could not reproduce the 
published findings. As Ladi et al. (2005) did not provide any immunofluorescence data to 
show the protein distribution in the cell, stainings with antibodies against different epitopes 
were performed to verify the distinct protein localization of DLL1 and DLL3. Confocal 
images revealed that DLL3 invariably localized to perinuclear structures inside the cell. 
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Moreover, the use of antibodies detecting either the intra- or the extracellular domain of 
DLL3 excluded that this intracellular staining is caused by protein cleavage.  
Finally, the intracellular localization of DLL3 was confirmed in vivo by immunofluorescence 
staining of the presomitic mesoderm of wildtype E9.5 mouse embryos where endogenous 
Dll1 and Dll3 are coexpressed at high levels. While DLL1 was readily detected on the cell 
surface, DLL3 predominantly resided within the presomitic mesoderm cells and colocalized 
with DLL1 only in perinuclear regions. Verifiying the differential protein localization of 
DLL1 and DLL3, subcellular colocalization studies with organelle markers demonstrated an 
accumulation of DLL3 in the Golgi network in vivo. DLL3 colocalized with the cis-Golgi 
marker GM130 but not with the membrane marker pan-Cadherin whereas DLL1 expression 
clearly overlapped with membrane staining. Since in the presomitic mesoderm DLL1 and 
DLL3 were expressed at physiological levels this in vivo evidence was most important to 
exclude that the observed intracellular localization of DLL3 is due to artifacts by 
overexpressed protein. In addition, the absence of DLL3 from the cell surface is supported by 
localization studies in flies by Dr. Robert Jaekel and Dr. Thomas Klein (University of 
Cologne, Germany). DLL3 expressed in D. melanogaster wing disc cells does not localize to 
the apical membrane (Geffers et al., 2007). Although not yet experimentally proven, it cannot 
be excluded that extensive recycling of the protein leads to lower steady state levels of the 
DLL3 protein on the cell surface. Even though the majority of DLL3 probably never reaches 
the cell surface - as observed in fly cells, in overexpressing CHO cells and in the murine 
presomitic mesoderm - it cannot be fully excluded that minor amounts of DLL3 might be 
sufficient for its biological function on the cell surface. 
5.2 The transmembrane domain and surrounding 
sequences of DLL3 account for protein retention 
Since DLL3 contains a predicted signal peptide at its N-terminus but appears to be absent 
from the cell surface, some retention signal seems to be present in its protein sequence. 
Interactions of specific sequences of DLL3 with other proteins located in the Golgi network 
might account for its confinement to intracellular compartments.  
Chimeric ligands A-G composed of domains of DLL1 and DLL3 (Fig. 4.9) differed in their 
propensity to localize to the cell surface as determined by cell surface biotinylation although 
the N-terminus of DLL1 carrying a signal peptide responsible for the post-translational 
transport to the secretory pathway was present in all these chimeras. Comparing the total 
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protein level with the protein amount on the cell surface, chimeric ligands A, C and G 
(Fig. 4. 9) displayed a diminished cell surface presentation. Chimeric ligand A containing the 
N-terminus and DSL domain of DLL1 linked to the EGFs and intracellular domain of DLL3 
was detected at the cell surface, albeit at much lower levels than the wildtype DLL1 protein. 
Chimeric ligands C and G contain the transmembrane (and intracellular) domain of DLL1 but 
the juxtaposed extracellular sequence of DLL3. Both chimeras exhibited a reduced propensity 
to localize at the cell surface. This decreased surface presentation was confirmed in 
immunofluorescence stainings. Although protein was detected on the cell surface of both cell 
lines, not all cells showed surface presentation of the ligands to a comparable extent. All three 
chimeric proteins contained the transmembrane domain of DLL3 and/or the juxtaposed 
extracellular DLL3 sequence indicating that these sequences might compose a Golgi retention 
signal. So far, there is no consensus sequence for Golgi retention described in the literature 
(Moore, 2003). However, the requirement of the transmembrane region of DLL3 for Golgi 
retention was consistent with findings in other Golgi-retained proteins, such as 
glycosyltransferases, though these enzymes are type II transmembrane proteins (Colley, 
1997). In contrast, chimeric ligand B that also comprised the DLL3 transmembrane sequence 
showed nearly normal levels of protein on the cell surface. This ligand contains only DLL1 
sequence in its extracellular domain indicating that the juxtaposed extracellular DLL3 region 
is also required for Golgi retention of the DLL3 protein. Consistently, a chimera consisting of 
the extracellular domain of DLL3 and the TM-ICD of DLL1 exhibits no surface expression. 
Collectively, the transmembrane domain of DLL3 together with adjacent extracellular 
sequences appears to contain some localization signal responsible for protein retention inside 
the cell and localization in the Golgi apparatus. 
In further subcellular localization analyses, the DLL1 DSL domain appeared to be necessary 
to direct cell surface expression. Chimeric ligands containing only the N-terminus of DLL1 
fused to DLL3 DSL domain and EGF repeats (chimeras J and M in Fig. 4. 10) exhibited no 
detectable membrane localization.  
The presence of both confined regions, the DSL domain of DLL1 and the transmembrane 
region of DLL3 together with juxtamembrane sequences, led to ambiguous protein 
localization on the cell surface and within the cell. 
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5.3 Mutations of conserved motifs of the DLL1 DSL 
domain influence surface presentation 
With regard to protein localization, the DSL domain of DLL3 could not substitute for the 
DSL domain of DLL1 as chimeras differing only in their DSL domain displayed different 
protein localization. On the amino acid level, the DSL domain of DLL3 greatly diverges from 
that of other Delta homologues. In addition to an altered spacing of conserved cysteine 
residues, two highly conserved amino acid motifs (YY and GWxG) are absent in the DLL3 
DSL domain. In this study it was experimentally demonstrated that non-conservative 
alteration of either motif had an impact on the propensity of the generated DLL1 variants to 
localize to the cell surface. Conservative mutations of the double tyrosine motif (like the 
exchange of one of the tyrosines to a similar aromatic amino acid as phenylalanine in DLL1 
variants DLL1 DSL-FY and DLL1 DSL-YF) did not change cell surface presentation. 
However, the loss of either both hydroxyl groups or of one of the aromatic rings influenced 
the localization of the mutant DLL1 protein. Semi-conservative mutations of either both 
tyrosines into phenylalanines (DLL1 DSL-FF) or of only one tyrosine into an alanine (DLL1 
DSL-AY) reduced protein presentation on the cell membrane since a large fraction of the 
protein was detected inside the cell. DLL1 variants that lack both aromatic residues in the 
DSL domain (DLL1 DSL-∆Y) resided within the cell. The replacement of the GWxG motif in 
the DSL domain by four alanine residues (DLL1 DSL-∆G) also partially impeded cell surface 
presentation of this DLL1 version. 
According to modification predictions the tyrosines Y182 and Y183 in the DLL1 DSL 
domain might represent a sulfation site. Friederich et al. (1988) demonstrated that inhibition 
of tyrosine O-sulfation blocks protein secretion. Therefore mutation of these tyrosines might 
abolish sulfation and subsequent transport to the membrane. Additionally, it is conceivable 
that this potential modification might influence the affinity of DLL1 to Notch, as tyrosine O-
sulfation was also implicated in protein-protein interaction (Wilkins et al., 1995). However, it 
is unlikely that this modification occurs in DLL1, since no radioactive signal could be 
detected after metabolic labeling with [35S]-sulfate of DLL1 expressing CHO cells and 
subsequent immunoprecipitation.  
Recently, the DSL domain of Jagged1 was crystallized and the structure solved (Penny 
Handford, Univ. of Oxford, UK, personal communication). A comparison of the sequence of 
the DLL1 DSL domain with the three-dimensional model of the Jagged1 DSL domain allows 
a prediction of the relative position of these two conserved amino acid motifs within this 
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domain. The alignment reveals that both conserved motifs, the YY and the GWxG motif, 
presumably lie in the hydrophobic core preserving the intramolecular structure of the DSL 
domain. The YY motif seems to be involved in the connection of the N-terminus of the DSL 
domain with the part that resembles an EGF domain via hydrophobic interactions (Penny 
Handford, Univ. of Oxford, UK, personal communication). The perturbation of efficient 
folding by mutations of the conserved motifs in the DLL1 DSL domain is likely to account 
for the retention of the misfolded protein during its passage through the secretory pathway. 
Possibly, the perturbation of the DSL domain also leads to a rapid degradation of the protein 
in consequence of ER stress induced by misfolded protein. 
5.4 Forced retention of a DSL protein cannot rescue DLL3 
function 
Concerning cell surface presentation and subcellular localization, DLL3 and the DLL1 
variant, DLL1 DSL-∆Y, displayed similar properties. Both proteins were virtually absent 
from the cell surface and colocalized partially with the cis-Golgi marker GM130. Mice that 
were heteroallelic for the Dll1Dll1DSL∆Y allele and homozygous mutant for Dll3pudgy showed a 
severely perturbed vertebral column similar to the pudgy phenotype indicating that mutant 
DLL1 present in the Golgi apparatus can not adopt DLL3 function. The Dll1Dll1DSL∆Y allele 
even seemed to enhance the pudgy phenotype but due to low numbers of skeletons analyzed 
thus far one cannot draw clear conclusions from this data. The failure of DLL1 DSL-∆Y to 
rescue the loss of functional DLL3 is unlikely to be due to differences in their somite 
expression pattern since the DLL3 protein expressed from the Dll1 locus in the Dll3 knock-in 
approach appeared to fully rescue the loss of wildtype endogenous Dll3 (data by Dr. Katrin 
Serth; Geffers et al., 2007). Apart from its differences in protein localization, DLL3 function 
might rely on specific properties of the EGF-like repeats and the DSL domain that might 
simultaneously abolish its activating function as a Notch ligand. Previously characterized 
missense mutations in EGF2, 4 and 5 of Dll3 each display a loss-of-function phenotype in 
mice indicating that the EGF-like repeats are essential for the correct function of DLL3 during 
somitogenesis (Shinkai et al., 2004; Turnpenny et al., 2003).  
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5.5 Conserved motifs in DLL1 DSL domain are essential 
for transactivation but not for cis-inhibition of Notch 
Proper three-dimensional folding of the DSL domain of Jagged1 is essential to present the 
Notch binding site on the surface of the conserved DSL domain (Penny Handford, Univ. of 
Oxford, UK, personal communication). Thus, loss of aromatic tyrosine residues or the GWxG 
motif destabilizing the overall DSL domain folding in Notch ligands would affect the shape of 
the Notch binding site and accordingly the potential to activate Notch. 
Consistent with these predictions, mutations of the DLL1 DSL domain preserving one 
tyrosine residue (DLL1 DSL-FY and DLL1 DSL-AY) induced Notch in transactivation 
assays, though to a strongly diminished extent. In contrast, the loss of the GWxG motif 
completely abolished Notch activation. Loss of both tyrosine residues led to an impaired cell 
surface presentation not allowing conclusions about the potential of the DLL1 variant to 
activate Notch. 
The generated DLL1 DSL mutant proteins did not efficiently transactivate Notch, presumably 
because they contain a more or less perturbed DSL domain. However, all of them were able to 
cell-autonomously inhibit Notch1 when coexpressed with the receptor. These observations 
suggest that the interaction of Notch1 with coexpressed ligands does not require a functional 
DSL domain. Dlk1, a protein belonging to the epidermal growth factor (EGF)-like homeotic 
family, negatively regulates Notch signaling through interactions with specific EGF-like 
repeats (Baladron et al., 2005; Nueda et al., 2007). The protein structure of Dlk1 shows 
similarities to DLL3 but does not contain any DSL domain indicating that the interplay of 
EGF-like repeats themselves might be sufficient to induce an impeding effect on Notch 
signaling. Itoh et al. (2003) showed that the lack of the ICD of Xenopus Delta1 does not 
disrupt the cell-autonomous association and inhibition of Notch suggesting that the ICD and 
ICD-related processes such as endocytosis are dispensable for the cis-inhibition of Notch 
signaling. These findings rather point to an “unspecific” association of EGF-containing 
proteins in vitro and do not necessarily prove that all these proteins can interact with Notch in 
vivo. 
Additionally, DLL3 and DLL1 DSL-∆Y exerted cell-autonomous inhibitory functions on 
Notch signaling although they resided within the cell. These findings are consistent with 
literature reporting that in vertebrates cis-interaction of Notch with its ligand occurs inside the 
cell, probably in the ER or the Golgi apparatus (Sakamoto et al., 2002). In contrast, in 
Drosophila inhibition of Notch function by coexpressed Serrate appeared to originate from 
cis-interactions at the cell surface (Glittenberg et al., 2006). 
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5.6 The DSL domain, EGF-like repeat 1 and 2 and the 
intracellular domain of DLL1 are required for Notch 
activation 
DLL3 lacks sequences in its DSL domain that are otherwise conserved among Delta 
homologues. Mutations of these sequences in the DSL domain of DLL1 abolished its 
function. According to this, it is questionable whether DLL3 could activate Notch signaling 
even if it would be present on the cell surface. Transactivation analyses of chimeric ligands 
present on the cell surface and comprised of different protein domains of DLL1 and DLL3 
(performed as detailed in Fig. 9 A) allow one to draw conclusions regarding the regions 
necessary for the function of DLL1 as an activating ligand. Additionally, the question of 
functional equivalence of the EGF-like repeats of DLL1 and DLL3 was addressed by this 
approach.  
Although the DSL domain was shown to be responsible for Notch binding (Shimizu et al., 
1999), transferring the N-terminus including the DSL domain of DLL1 to the EGF-like 
repeats of DLL3 resulted in a non-activating ligand indicating that the DSL domain of DLL1 
is not sufficient to confer transactivation potential on DLL3.  
Additionally, the intracellular domain (ICD) of DLL1 is required for its function as a Notch 
ligand since the lack of the ICD or the replacement of the TM-ICD by the corresponding 
DLL3 sequence led to a complete abolishment of Notch transactivation. The intracellular 
domain of DLL3 is highly divergent from DLL1 and lacks several features that might be 
important for Notch activation. For instance, the C-terminus of DLL1 constitutes a PDZ 
ligand binding motif which was recently shown to mediate interactions with members of the 
MAGUK (membrane-associated guanylate kinase) protein family (Pfister et al., 2003; Six et 
al., 2004; Wright et al., 2004). As the binding of PDZ domain-containing proteins depends on 
the presence of a C-terminal valine in DLL1 a C-terminal tag is likely to interfere with this 
interaction. However, DLL1 full length protein carrying a C-terminal tag was able to 
transactivate Notch1 in coculture experiments suggesting that processes associated with PDZ 
binding are not required for Notch signaling per se. This is further supported by the fact that a 
variant of the Notch ligand DeltaD that cannot interact with PDZ domains exhibits no Notch 
phenotype in zebrafish (Wright et al., 2004).  
Furthermore, the ICD of DLL1 is involved in processes such as ubiquitin-mediated 
endocytosis and multimerization. Trafficking of Notch ligands by endocytosis was shown to 
be initiated by the RING E3 ubiquitin ligases, Mindbomb and Neuralized (Itoh et al., 2003; 
Lai and Rubin, 2001; Lamar et al., 2001; Nam et al., 2006; Pavlopoulos et al., 2001). Both 
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enzymes interact with short amino acid motifs in the ICD of the Notch ligand Serrate to 
ubiquitinate specific lysines thereby targeting the protein for internalization by the 
endocytotic machinery (Overstreet et al., 2004). Simultaneous absence of Neuralized and 
Mindbomb completely abolished Notch signaling in Drosophila indicating that ubiquitination 
is a prerequisite for Delta signaling (Lai et al., 2005; Pitsouli and Delidakis, 2005). Deletion 
of the interacting motif or substitution of the lysine residues by alanine severely compromised 
ligand internalisation and Notch activation (Glittenberg et al., 2006). Consistent with the 
requirement of ubiquitin-mediated endocytosis, substitution of the Delta ICD by an 
endocytotic motif of an unrelated transmembrane protein or ubiquitin itself resulted in an 
active ligand (Itoh et al., 2003; Wang and Struhl, 2004; Wang and Struhl, 2005).  
Moreover, endocytosis is involved in dissociation of the Notch heterodimer after ligand 
binding and removal of the Notch extracellular domain (NECD) which is a prerequisite for 
the Notch ectodomain shedding by the metalloprotease TACE (see chapter 1.3). For instance, 
the loss of E3 ligase in Mindbomb1 mutant mice resulted in a disruption of Notch signaling as 
these embryos failed to generate activated Notch ICD (Barsi et al., 2005; Koo et al., 2005).  
Findings that the signal-transducing activity of soluble DLL1 was enhanced by antibody-
mediated cross-linking indicates that multimerization of Notch ligands mediated by the 
intracellular domain also affects activation of Notch (Hicks et al., 2002; Shimizu et al., 2002). 
Drosophila Delta and Serrate proteins lacking their ICD acted to antagonize the function of 
the full-length ligands (Fleming et al., 1997; Sun and Artavanis-Tsakonas, 1996). 
Additionally, the soluble ligand form impaired the transactivation activity of full length Delta 
when coexpressed in the same cell (Shimizu et al., 2002). These observations imply a link 
between endocytosis, clustering and Notch signaling. 
As the DLL3 ICD lacks lysine residues required for ubiquitin-conjugation, one can assume 
that the chimeric ligand comprised of the extracellular part of DLL1 and the TM-ICD of 
DLL3 is incapable to activate Notch due to a loss of ubiquitin-dependent processes or other 
modifications. Emphasizing the importance of ICD-mediated processes for Notch activation, 
a truncated DLL1 ligand lacking the ICD did not transactivate although efficiently presented 
on the cell surface.  
A chimera composed of the N-terminal part of DLL1 including DSL and EGF domain 1 and 
2, the six EGF repeats of DLL3 and the TM-ICD of DLL1 exhibited activating properties 
albeit weaker than the wildtype indicating that the two distal EGF repeats and the DSL 
domain of DLL1 are sufficient for Notch activation. Consistent with this finding is the 
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requirement for the DSL domain and EGF repeats 1 and 2 of Jagged1 for Notch binding in 
vitro (Shimizu et al., 1999). 
Substitution of the EGF-like repeats 1 and 2 in DLL1 by those of DLL3 with or without 
correct spacing led to a complete derogation of Notch signaling although both proteins 
localized to the cell membrane. These observations indicate that DLL1 EGF-like repeats 1 
and 2 which are highly conserved among Delta homologues have specific properties that are 
not present in repeats 1 and 2 of DLL3. Interestingly, the disruption of the domain structure of 
EGF 1 or 2 of DLL1 by mutating conserved cysteines was sufficient to impair DLL1 function 
in vitro and in vivo (Geffers, Müller and Gossler, unpublished observations; Cordes, Schuster-
Gossler and Gossler, unpublished observations). While mutation of EGF-like repeat 1 
abolished cell surface presentation, DLL1 protein with a disrupted EGF-like repeat 2 localized 
to the cell membrane but showed no transactivation potential.  
In addition to the requirement of EGF-like repeat 1 and 2 of DLL1, the correct spacing of 
these EGF repeats in DLL1 is essential for Notch activation as alteration of the length of the 
spacer sequence resulted in a loss of DLL1 function. EGF 1 and 2 might support the binding 
of the DLL1 DSL domain to Notch by additional interaction with EGF repeats of Notch. 
Concerning the functional equivalence of the EGF-like repeats of DLL1 and DLL3, EGFs 4 to 
8 of DLL1 resemble EGFs 2 to 6 of DLL3 by sequence. These EGF repeats were exchanged 
in DLL1 without diminishing its Notch activating capacity. On the contrary, in transactivation 
assays this chimeric ligand induced even higher Notch activity in the receiving cells than the 
DLL1 wildtype. This effect might also be due to different expression levels as it was not 
possible to obtain CHO cell lines with closely matching levels of protein expression.  
Analyzing the exchangeability of the EGF-like repeats of DLL1 and DLL3, not only the 
protein sequence of these domains but also modification sites has to be considered. Similar to 
the Notch receptors, Notch ligands might be targeted by glycosyltransferases Pofut1 and 
Fringe that participate in the synthesis of O-linked fucose glycans attached to EGF repeats 
(Haines and Irvine, 2003; Haltiwanger and Lowe, 2004; Moloney et al., 2000a; Panin et al., 
2002). 
In DLL1, five of the eight present EGF-like repeats carry potential consensus sequences for 
O-fucosylation: EGF 2, 3 and 8 have a broad consensus site, EGF 4 and 7 display a narrow O-
fucose consensus site. Similarly, the narrow O-fucosylation site is present in EGF2 and 5 of 
DLL3 which are homologuous to EGF 4 and 7 of DLL1 (Panin et al., 2002). There is 
evidence that Dll1 and Jagged1 incorporate O-fucose that is in turn elongated by Fringe in 
vitro (Panin et al., 2002). Metabolic labeling demonstrated that DLL3 also served as a 
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substrate for O-fucosylation by Pofut1 (Müller and Gossler, unpublished observations). 
However, which of the potential fucosylation sites are modified in DLL1 and DLL3 in vivo 
still needs to be shown. The highly conserved DLL1 EGF repeat 2 together with EGF repeat 3 
- both containing potential fucosylation sites - are missing in the DLL3 protein. Concerning 
the involvement of EGF1 and 2 of DLL1 in Notch activation the potential O-fucosylation in 
EGF-like repeat 2 of DLL1 may accessorily play a role in this context. Although the exact 
functional significance to these modifications is yet unknown it was suggested that O-
fucosylation might facilitate ligand multimerization (Chitnis, 2006). 
5.7 DLL3 is not an antagonist of DLL1 in vivo 
On the basis of a detailed analysis of genetic interactions, Takahashi et al. (2003) suggested 
that DLL1 and DLL3 may have non-redundant, even counteracting functions. However, their 
conclusions were based on the assumption that DLL3 is able to activate Notch signal 
transduction.  
Dunwoodie et al. (2002) discussed the possibility that the obvious differences in expression of 
Notch target genes in the PSM of Dll1 and Dll3 mutants do not reflect distinct functions but 
are rather due to the same function that affects target gene expression to different extents. The 
authors proposed that this issue could best be addressed by a cDNA knock-in approach that 
replaces Dll1 by Dll3 or vice versa.  
In this study two mouse lines were generated expressing the Dll3 and Dll3HA cDNA, 
respectively, under the regulatory control of Dll1. Analyses of these mutant mice (performed 
by Dr. Katrin Serth; Geffers et al., 2007) revealed that the phenotype of homozygous 
Dll1Dll3HAki embryos was virtually indistinguishable from the Dll1 null phenotype as antero-
posterior somite patterning (indicated by Uncx4.1 expression) and cyclic gene expression of 
the Notch modulator Lfng were similarly affected in both cases. These observations 
demonstrate that, consistent with in vitro findings, Dll3 cannot substitute for Dll1 in vivo. 
However, DLL3 protein generated from the knock-in allele was functional as the Dll3 null 
phenotype was rescued by Dll3 expression from the Dll1Dll3HAki allele. Mice that were 
homozygous mutant for the null allele Dll3pu but heteroallelic for the Dll1 wildtype and the 
Dll1Dll3 knock-in alleles showed normal axial skeleton development as well as normal cyclic 
Lfng expression and stripy expression of Uncx4.1 in embryos of this genotype.  
Given that the disrupted antero-posterior somite patterning of pudgy mice is restored in 
Dll1Dll3HAki/+; Dll3pu/pu embryos, the knock-in into the Dll1 locus might serve as an in vivo 
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assay to define features or protein domains of DLL3 responsible for its function. Additionally 
this knock-in approach shows that loss of distinct expression of Dll3 in the anterior half of the 
somites does not influence the normal development of the vertebral column. Moreover, 
ectopic expression of Dll3 in the posterior halves of the formed somites does not interfere 
with DLL1 function.  
To investigate how DLL3 affects Notch activation in vivo the protein levels of activated 
Notch intracellular domain (NICD) in mouse PSM were analyzed by Western blot with anti-
cleaved Notch antibodies. If DLL3 would act as an antagonist of Notch signaling during 
somitogenesis the loss of DLL3 should lead to an enhancement of Notch signaling and higher 
levels of activated NICD. However, the PSMs of pudgy embryos displayed slightly decreased 
activated NICD levels when compared to the wildtype PSM, thus – if anything - supporting a 
Notch activating potential of DLL3. As a control, PSMs of homozygous Dll1Dll3HAki mice 
were analyzed. Since the Notch ligand Dll1 is eliminated and replaced by Dll3 which proved 
not to activate Notch in vitro, signal transduction via these ligands is assumed to be 
completely disrupted in this tissue. Consistently, only very low levels of activated NICD were 
detected in these samples, probably originating from signal induction via another Notch 
ligand. Jagged1 might account for this Notch activation as it is strongly expressed in the 
posterior half of the forming somite, the tailbud and at low levels in the PSM (Shi and 
Stanley, 2003). However, Jagged1-induced signal transduction in the PSM seems to be 
dispensable for somitogenesis as Jagged1 null mutant embryos lack any detectable somite 
phenotype (Xue et al., 1999). Consistently, altering the ratio of Dll3 to Dll1 in vivo by 
combination of different Dll3 and Dll1 mutant alleles revealed no genetic evidence for 
antagonism of DLL3 and DLL1 during somitogenesis (data by Dr. Katrin Serth; Geffers et al., 
2007).  
Taken together our observations suggest that DLL3 does not obviously inhibit Notch 
signaling in vivo though it was shown that coexpression of DLL3 and Notch1 leads to cell-
autonomous inhibition of Notch signaling in vitro (Ladi et al., 2005). DLL3 seems to have a 
different function - possibly even outside the Notch pathway - as it is not acting as a simple 
Notch activator or antagonist. 
5.8 Potential DLL3 functions 
DLL3 does not exert pivotal functions outside somitogenesis as Dl3 mutant mice survive 
though with an extremely perturbed vertebral column (Grüneberg, 1961; Kusumi et al., 1998). 
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The normal function of DLL3 requires the protein to be anchored into the membrane. 
Mutations in the transmembrane domain of DLL3 resulting in a soluble extracellular DLL3 
domain - due to protein truncation - produced a Dll3 null allele (Turnpenny et al., 2003).  
Though harboring a signal peptide at its N-terminus, DLL3 appears to be absent from the cell 
surface. Therefore a direct contact between proteins on the neighboring cell surface and DLL3 
appears unlikely. Analysis of the subcellular localization of stable CHO cell lines expressing 
chimeric ligands by either cell surface labeling or immunofluorescence and transactivation 
assays of these ligands revealed that DLL3 has acquired sequences that promote Golgi 
retention and several structural changes that are sufficient to abrogate Notch activating 
function. Furthermore, DLL3 involvement in processes such as ubiquitin-mediated 
endocytosis or those associated with PDZ-containing proteins seems improbable, as its 
intracellular domain lacks lysine residues required for ubiquitin-conjugation and the C-
terminal PDZ binding motif present in other Delta homologues. Additionally, the absence of 
nuclear localization signals in the DLL3 intracellular domain eliminates the possibility to 
directly translocate to the nucleus as described for DLL1 ICD but it does not exclude that 
DLL3 ICD might act as a transcriptional regulator when co-transported together with other 
proteins into the nucleus (Hiratochi et al., 2007; Ikeuchi and Sisodia, 2003; Six et al., 2003). 
Collectively, DLL3 differs from DLL1 with respect to protein localization and its potential to 
interact with proteins such as E3 ligases and PDZ-containing proteins. 
Intra- rather than intercellular associations of DLL3 with other proteins might be important 
for DLL3 function. Interacting intracellular partners could be Notch receptors and/or Notch 
ligands on their way through the secretory pathway to the cell surface. As the majority of 
DLL3 protein localizes to the Golgi apparatus, this cell compartment could present the site of 
association with potential interaction partners. DLL3 colocalization with DLL1 in 
intracellular structures of presomitic mesoderm cells, as reported in this study, raises the 
possibility that these proteins interact. 
Most strikingly, a Notch modulator, the glycosyltransferase lunatic fringe (Lfng), which 
catalyzes the elongation of O-fucose linked to EGF repeats of Notch receptors and ligands, 
also resides within the Golgi network (Hicks et al., 2000). 
Dll3 and Lfng are largely coexpressed in the PSM, the somites and the neural tube. Despite 
subtle defects in the central nervous system of pudgy mice, Dll3 null alleles cause skeletal 
defects by a disruption of the antero-posterior patterning of the somites. This phenotype is 
remarkably similar to that of mice carrying either Lfng loss-of-function or gain-of-function 
mutations (Serth et al., 2003; Zhang et al., 2002).  
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Ladi et al. (2005) demonstrated that DLL3 interferes with DLL1-induced Notch signaling by 
cis-inhibition and that expression of Lfng can override the inhibitory effect of DLL3. 
Additionally, as DLL3 was shown to be O-fucosylated in vitro (Müller and Gossler, 
unpublished observations), EGF-like repeats 2 and 5 of DLL3 that carry narrow O-
fucosylation sites might be substrates of Lfng. These findings point to a potential interaction 
of DLL3 and Lfng which has to be investigated in more detail. As cis-inhibition seems not to 
interfere with cell surface presentation of Notch it remains an open question how this 
mechanism regulates Notch activity (Sakamoto et al., 2002). Though coexpression of Lfng in 
vitro diminishes ligand-dependent cell-autonomous inhibition of Notch signaling (Ladi et al., 
2005; Sakamoto et al., 2002), intracellular ligand-receptor interactions might still influence 
the interaction of Notch with POFUT and/or Lfng under physiological conditions. As a 
potential consequence, this might prevent crucial modifications of the Notch receptor. Thus, a 
modulatory effect on Notch signaling might emenate from DLL3 interactions with Lfng.  
In Drosophila a Notch chaperone activity was demonstrated for the glycosyltransferase 
OFUT1 which was independent of its fucosyltransferase activity. Interaction of Notch with 
OFUT1 promoted normal folding of Notch in the endoplasmic reticulum and trafficking of 
Notch to the cell membrane (Okajima et al., 2005). Additionally, OFUT1 served as an 
extracellular component that was essential for the constitutive endocytic trafficking of Notch 
in Drosophila (Sasamura et al., 2007). Similarly, it is conceivable that intracellular DLL3 acts 
as a scaffold protein involved in trafficking or that its function comprises chaperone activity 
for other components of the Notch signaling pathway. Thus, Notch signaling might be 
directly or indirectly modulated by intracellular interactions of DLL3.  
During evolution similar mechanisms emerge by the usage of different components. For 
instance, in fish and frog, oscillating expression of Delta-like ligands during somitogenesis 
evoke rhythmic changes in Notch signaling required for somite formation (Jiang et al., 2000). 
In contrast, in mouse and chick, oscillations in Notch signaling in the presomitic mesoderm 
are generated by the wavelike expression of the Notch modifier Lfng while ligand expression 
in the caudal PSM is relatively uniform (Aulehla and Johnson, 1999; Forsberg et al., 1998).  
As Dll3 is only described for mammals, it might represent a novel intracellular component of 
Notch signaling, a modulator that has evolved in mammals and fulfils a function that is 
accomplished by other proteins in Dll3-lacking species like fish and frog.  
Data obtained in this study unambiguously show that DLL3 does not transactivate Notch 
signaling and localizes to intracellular compartments including the cis-Golgi network. This 
provides first evidence that DLL3 might functions as an intracellular component of the Notch 
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signaling pathway. Although DLL3 interacts with Notch and the Dll3 null phenotype is 
similar to that of Lfng (Ladi et al., 2005), at this point it cannot completely be ruled out that in 
addition to this Dll3 exerts functions independent from Notch. 
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Table 1: Cell clones used for this thesis and their origins  
Figure  CHO cell line Cell clone Generated by Subcloned by 
4.2 left panel Dll1Flag  #A7 I.G.  
 Dll3HA #A5 I.G.  
4.2 right panel Dll1Flag #A7/A1 I.G. I.G. 
 Dll3Flag #C3/38 I.G. K.S./P.D.-H. 
4.3 Dll1Flag #A7/A1 I.G. I.G. 
 Dll3Flag #C3/38 I.G. K.S./P.D.-H. 
 Dll3HA #A5 I.G.  
4.4 Dll1Flag #A7/A1 I.G. I.G. 
 Dll3Flag #C3/38 I.G. K.S./P.D.-H. 
 Dll3HA #A5 I.G.  
4.5 Dll3Flag #C3/38 I.G. K.S./P.D.-H. 
4.9 Dll1Flag #A7/A1 I.G. I.G. 
 A #A5/8 K.S./P.D.-H. K.S./P.D.-H. 
 B #A3 K.S./P.D.-H. - 
 C #18/10 K.S./P.D.-H. K.S./P.D.-H. 
 D #14 I.G. - 
 E #B2 K.S./P.D.-H. - 
 F #B11 K.S./P.D.-H. - 
 G #A2/C5 K.S./P.D.-H. K.S./P.D.-H. 
 H #13 K.S./P.D.-H. - 
4.10 Dll1Flag #A7/A1 I.G. I.G. 
 A #A5/8 K.S./P.D.-H. K.S./P.D.-H. 
 B #A3 K.S./P.D.-H. - 
 C #18/10 K.S./P.D.-H. K.S./P.D.-H. 
 G #A2/C5 K.S./P.D.-H. K.S./P.D.-H. 
 H #13 K.S./P.D.-H. - 
 I #B3 I.G. - 
 J #6 I.G. - 
 K #B11/2C5 K.S./P.D.-H. K.S./P.D.-H. 
 L #E1 K.S./P.D.-H. - 
 M #7 I.G. - 
4.12 Dll1Flag #A7/A1 I.G. I.G. 
 Dll3Flag #C3/38 I.G. K.S./P.D.-H. 
 DLL1 DSL-∆Y #16/6 I.G. I.G. 
 DLL1 DSL-∆G #16/8 I.G. I.G. 
 DLL1 DSL-AY #13/11 C.B. I.G. 
 DLL1 DSL-FY #3/5 C.B. I.G. 
4.13 Dll1Flag #A7/A1 I.G. I.G. 
 DLL1 DSL-∆Y #16/6 I.G. I.G. 
 DLL1 DSL-∆G #16/8 I.G. I.G. 
 DLL1 DSL-AY #13/11 C.B. I.G. 
 DLL1 DSL-FY #3/5 C.B. I.G. 
 DLL1 DSL-YF #1 I.G.  
 DLL1 DSL-FF #22 I.G.  
4.14 DLL1 DSL-∆Y #16/6 I.G. I.G. 
4.15 Dll1Flag #A7/A1 I.G. I.G. 
 Dll3Flag #C3/38 I.G. K.S./P.D.-H. 
 DLL1 DSL-∆Y #16/6 I.G. I.G. 
 DLL1 DSL-∆G #16/8 I.G. I.G. 
 DLL1 DSL-AY #13/11 C.B. I.G. 
 DLL1 DSL-FY #3/5 C.B. I.G. 
     C.B.: Claudia Brockmeyer 
I.G.: Insa Geffers 
K.S./P.D.-H.: Dr. Katrin Serth with technical assistence from Patricia Delany-Heiken 
